F&G Annuities & Life, Inc.: Form 10-Q for the period ended Sep 30, 2023
Filed with the SEC on Nov 8, 2023 and accepted by EDGAR at Nov 8, 2023, 16:11 ET.
Management's discussion and analysis
As filed, 110,918 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The statements contained in this Quarterly Report on Form 10-Q that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding our expectations, hopes, intentions or strategies regarding the future. All forward-looking statements included in this document are based on information available to us on the date hereof, and we assume no obligation to update any such forward-looking statements. It is important to note that our actual results could vary materially from those forward-looking statements contained herein due to many factors, including, but not limited to: the potential impact of our business relationships, including with our employees, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; weakness or adverse changes in the level of activity in our sector or the sectors of our affiliated companies, which may be caused by, among other things, high or increasing interest rates, or a weak U.S. economy; significant competition that our operating subsidiaries face; compliance with extensive government regulation; and other risks detailed in the "Statement Regarding Forward-Looking Information," "Risk Factors" and other sections of our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the SEC.
The following discussion should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2022, filed on February 27, 2023, as amended by Amendment No. 1 on Form 10-K/A filed on April 27, 2023, (collectively our “Annual Report”) and our Current Report on Form 8-K, filed on July 13, 2023, to update our Annual Report for changes in accounting for long-duration contracts by insurance companies as discussed below in “Overview.”
Overview
For a description of our business, including descriptions of recent business developments, see the discussion in Note A - Basis of Financial Statements in the accompanying unaudited Condensed Consolidated Financial Statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q, which is incorporated by reference into this Part I, Item 2.
We adopted Accounting Standards Update (“ASU”) 2018-12, Financial Services-Insurance (Topic 944), Targeted Improvements to the Accounting for Long-Duration Contracts (“ASU 2018-12”) on January 1, 2023, with a transition date of January 1, 2021, or the beginning of the earliest period that will be presented in the annual December 31, 2023 Consolidated Financial Statements. We elected to adopt ASU 2018-12 using the full retrospective transition method and balances for liability for future policy benefits (“FPB”), deferred acquisition costs ("DAC”) and balances amortized on a basis consistent with DAC, value of business acquired ("VOBA”), deferred sales inducements (“DSI”), and unearned revenue liabilities (“URL”), and market risk benefits (“MRB”) were adjusted to conform to ASU 2018-12 starting as of the FNF Acquisition Date, June 1, 2020 (the “FNF Acquisition Date”). The 2022 and 2021 financial information contained herein have been adjusted for our full retrospective adoption of this update
Business Trends and Conditions
The following factors represent some of the key trends and uncertainties that have influenced the development of the Company and its historical financial performance, and we believe these key trends and uncertainties will continue to influence the business and financial performance of the Company in the future.
Market Conditions
Market volatility has affected, and may continue to affect, our business and financial performance in varying ways. Volatility can pressure sales and reduce demand as consumers hesitate to make financial decisions. To enhance the attractiveness and profitability of our products and services, we continually monitor the behavior of our customers, as evidenced by annuitization rates and lapse rates, which vary in response to changes in market conditions. See “Risk Factors” in this Quarterly Report on Form 10-Q and Item 1A of Part I of our Annual Report for the year ended December 31, 2022 for further discussion of risk factors that could affect market conditions.
Interest Rate Environment
Some of our products include guaranteed minimum crediting rates, most notably our fixed rate annuities. As of September 30, 2023 and December 31, 2022, our reserves, net of reinsurance, and average crediting rate on our fixed rate annuities were $6 billion and 4%, respectively, and $6 billion and 3%, respectively. We are required to pay the guaranteed minimum crediting rates even if earnings on our investment portfolio decline, which would negatively impact earnings. In addition, we expect more policyholders to hold policies with comparatively high guaranteed rates for a longer period in a low interest rate environment. Conversely, a rise in average yield on our investment portfolio would increase earnings if the average interest rate we pay on our products does not rise correspondingly. Similarly, we expect that policyholders would be less likely to hold policies with existing guarantees as interest rates rise and the relative value of other new business offerings are increased, which would negatively impact our earnings and cash flows.
See “Quantitative and Qualitative Disclosure about Market Risk” and “Risk Factors” in this Quarterly Report on Form 10-Q for a more detailed discussion of interest rate risk.
Aging of the U.S. Population
We believe that the aging of the U.S. population will increase the demand for our fixed index annuity (“FIA”) and indexed universal life (“IUL”) products. As the “baby boomer” generation prepares for retirement, we believe that demand for retirement savings, growth, and income products will grow. Over 10,000 people will turn 65 each day in the United States over the next 15 years, and according to the U.S. Census Bureau, the proportion of the U.S. population over the age of 65 is expected to grow from 18% in 2023 to 21% in 2035. The impact of this growth may be offset to some extent by asset outflows as an increasing percentage of the population begins withdrawing assets to convert their savings into income.
Industry Factors and Trends Affecting Our Results of Operations
We operate in the sector of the insurance industry that focuses on the needs of middle-income Americans. The underserved middle-income market represents a major growth opportunity for us. As a tool for addressing the unmet need for retirement planning, we believe that many middle-income Americans have grown to appreciate the financial certainty that we believe annuities such as our FIA products afford. For example, the FIA market grew from nearly $12 billion of sales in 2002 to $79 billion of sales in 2022. Additionally, this market demand has positively impacted the IUL market as it has expanded from $100 million of annual premiums in 2002 to $3 billion of annual premiums in 2022.
See Item 7 of Part II of our Annual Report on Form 10-K for the year ended December 31, 2022 for a more detailed discussion of industry factors and trends affecting our Results of Operations.
Critical Accounting Policies and Estimates
The accounting estimates described in Item 7 of Part II of our Annual Report on Form 10-K for the year ended December 31, 2022 and as updated below for changes, including those required by the adoption of ASC 2018-12, are those we consider critical in preparing our Condensed Consolidated Financial Statements. Management is required to make estimates and assumptions that can affect the reported amounts of assets and liabilities and disclosures with respect to contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from those estimates. See Note A - Basis of Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for additional description of certain significant accounting policies that have been followed in preparing our Condensed Consolidated Financial Statements.
Reserves for Future Policy Benefits and Certain Information on Contractholder Funds
The determination of FPB reserves is dependent on actuarial assumptions. The principal assumptions used to establish liabilities for FPBs are established at issue of the contract and include discount rates, mortality, and cash surrender or policy lapse for our traditional life insurance products. The assumptions used require considerable judgment. We review policyholder behavior experience at least annually and update these assumptions when deemed necessary based on additional information that becomes available. Discount rate assumptions are updated at each reporting period and also incorporate changes in risk free rates and option market values. Changes in, or deviations from, the assumptions previously used can significantly affect our reserve levels and related results of operations in a positive or negative direction.
Mortality refers to the incidence of death on covered lives, which triggers contractual death benefit provisions. On our deferred annuities and life insurance products, these provisions may allow for lump sum payments, payments over a period of time, or spousal continuation of the contract. On our life-contingent immediate annuities, the death of a named annuitant or pension risk transfer (“PRT”) certificate holder may trigger the cessation or reduction of future life-contingent payments due, depending on the presence of a joint annuitant/certificate holder and any remaining guaranteed non-life contingent payment periods. We utilize a combination of internal and industry experience when setting our mortality assumptions.
A surrender rate is the percentage of account value surrendered by the policyholder in exchange for receipt of a cash surrender value. A lapse rate is the percentage of account value canceled by us due to nonpayment of premiums required to maintain coverage on our life insurance products. We make estimates of expected full and partial surrenders of our deferred annuity products, based on a combination of internal and industry experience. Management’s best estimate of surrender behavior generally represents a medium-to-long term perspective, as we expect to experience a range of policyholder behavior and market conditions period to period. If actual surrender rates are significantly different from those estimated, such differences could have a significant effect on our reserve levels and related results of operations.
Discount rates refers to the interest rates used to discount future cash flows to the current period to determine a present value. For liability for FPB reserves the discount rate used is based on the yield curve for A-rated corporate bonds as of the valuation date. Changes in the discount rates from the at-issue or at-purchase discount rates flow through other comprehensive income (“OCI”).
Our aggregate reserves for contractholder funds, FPBs and MRBs on a direct and net basis as of September 30, 2023 and December 31, 2022 are summarized as follows (dollars in millions):
| As of September 30, 2023 Direct | Deposit Asset/ Reinsurance Recoverable | Net | |
|---|---|---|---|
| Fixed indexed annuities (“FIA”) | $26,659 | $(17) | $26,642 |
| Fixed rate annuities | 11,991 | (5,963) | 6,028 |
| Single premium immediate annuities (“SPIA”) and other | 1,708 | (110) | 1,598 |
| IUL and other life | 3,625 | (1,372) | 2,253 |
| Funding agreement backed notes ("FABN") | 4,969 | — | 4,969 |
| PRT | 3,160 | — | 3,160 |
| Total | $52,112 | $(7,462) | $44,650 |
| As of December 31, 2022 Direct | Deposit Asset/ Reinsurance Recoverable | Net | |
|---|---|---|---|
| FIA | $24,704 | $(16) | $24,688 |
| Fixed rate annuities | 9,360 | (3,723) | 5,637 |
| SPIA and other | 1,829 | (118) | 1,711 |
| IUL and other life | 3,486 | (1,560) | 1,926 |
| FABN | 4,595 | — | 4,595 |
| PRT | 2,172 | — | 2,172 |
| Total | $46,146 | $(5,417) | $40,729 |
76
FIA and IUL products contain an embedded derivative; a feature that permits the holder to elect an interest rate return or an equity-index linked component, where interest credited to the contract is linked to the performance of various equity indices. The FIA/IUL embedded derivatives are valued at fair value and included in the liability for contractholder funds in our Condensed Consolidated Balance Sheets with changes in fair value included as a component of Benefits and other changes in policy reserves in our unaudited Condensed Consolidated Statements of Operations.
For life-contingent immediate annuity policies (which includes life-contingent PRT annuities), gross premiums received in excess of net premiums are deferred at initial recognition as a deferred profit liability (“DPL”). Gross premiums are measured using assumptions consistent with those used in the measurement of the related liability for FPBs.
Valuation of Fixed Maturity, Preferred and Equity Securities, and Derivatives and Reinsurance Recoverable
Our investments in fixed maturity securities have been designated as available-for-sale ("AFS") and are carried at fair value, net of allowance for expected credit losses, with unrealized gains and losses included within accumulated other comprehensive income (loss) ("AOCI"), net of deferred income taxes. Our equity securities are carried at fair value with unrealized gains and losses included in net income (loss). Realized gains and losses on the sale of investments are determined on the basis of the cost of the specific investments sold and are credited or charged to income on a trade date basis.
Management’s assessment of all available data when determining fair value of the AFS securities is necessary to appropriately apply fair value accounting. Management utilizes information from independent pricing services, who take into account perceived market movements and sector news, as well as a security’s terms and conditions, including any features specific to that issue that may influence risk and marketability. Depending on the security, the priority of the use of observable market inputs may change as some observable market inputs may not be relevant or additional inputs may be necessary. We generally obtain one value from our primary external pricing service. In situations where a price is not available from the independent pricing service, we may obtain broker quotes or prices from additional parties recognized to be market participants. We believe the broker quotes are prices at which trades could be executed based on historical trades executed at broker-quoted or slightly higher prices. When quoted prices in active markets are not available, the determination of estimated fair value is based on market standard valuation methodologies, including discounted cash flows, matrix pricing, or other similar techniques.
We validate external valuations at least quarterly through a combination of procedures that include the evaluation of methodologies used by the pricing services, comparisons to valuations from other independent pricing services, analytical reviews and performance analysis of the prices against trends, and maintenance of a securities watch list. See Note B - Fair Value of Financial Instruments and Note C - Investments to our Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.
The fair value of derivative assets and liabilities is based upon valuation pricing models or independent broker quotes and represents what we would expect to receive or pay at the balance sheet date if we canceled or exercised the derivative, or entered into offsetting positions. Fair values for instruments utilizing valuation pricing models are determined internally using a conventional model and market observable inputs, including interest rates, yield curve volatilities and other factors. Credit risk related to the counterparty is considered when estimating the fair values of these derivatives. However, we are largely protected by collateral arrangements with counterparties when individual counterparty exposures exceed certain thresholds. The fair value of futures contracts (specifically for FIA contracts) at the balance sheet date represents the cumulative unsettled variation margin (open trade equity net of cash settlements). The fair value of an interest rate swap represents the change in projected interest rates between the reporting date and the date the interest rate swap was executed. The fair values of the embedded derivatives in our FIA and IUL contracts are derived using market value of options, use of current and budgeted option cost, swap rates, mortality rates, surrender rates, partial withdrawals, and non-performance spread and are classified as Level 3. The discount rate used to determine the fair value of our FIA/IUL embedded derivative liabilities includes an adjustment to reflect the risk that these obligations will not be fulfilled (“non-performance risk”). For the nine months ended September 30, 2023 and the year ended December 31, 2022, our non-performance risk adjustment was based on the expected loss due to default in debt obligations for similarly rated financial companies. See Note B
- Fair Value of Financial Instruments and Note D - Derivative Financial Instruments to our Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.
As discussed in Note E - Reinsurance of our Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q, FGL Insurance entered into a reinsurance agreement with Kubera effective December 31, 2018, to cede certain MYGAs and other fixed rate annuity GAAP and statutory reserves on a coinsurance funds withheld basis, net of applicable existing reinsurance. Effective October 31, 2021, this agreement was novated from Kubera to Somerset. Additionally, FGL Insurance entered into a reinsurance agreement with Aspida Re effective January 1, 2021, and amended in August 2021, September 2022 and July 2023, to cede a quota share of MYGA business on a funds withheld basis. Fair value movements in the funds withheld balances associated with these arrangements create an obligation for FGL Insurance to pay Somerset and Aspida Re at a later date, which results in embedded derivatives. These embedded derivatives are considered total return swaps with contractual returns that are attributable to the assets and liabilities associated with the reinsurance arrangements. The fair value of the total return swaps are based on the change in fair value of the underlying assets held in the funds withheld portfolio. Investment results for the assets that support the coinsurance with funds withheld reinsurance arrangement, including gains and losses from sales, are passed directly to the reinsurer pursuant to contractual terms of the reinsurance arrangement. The reinsurance related embedded derivatives are reported in Prepaid expenses and other assets if in a net gain position, or Accounts payable and accrued liabilities, if in a net loss position on the Condensed Consolidated Balance Sheets. The related gains or losses are reported in Recognized gains and (losses), net on the unaudited Condensed Consolidated Statements of Operations.
Market Risk Benefits
MRBs are contracts or contract features that both provide protection to the contract holder from other-than-nominal capital market risk (equity, interest and foreign exchange risk) and expose the Company to other-than-nominal capital market risk. MRBs include certain contract features primarily on FIA contracts that provide minimum guarantees to policyholders, such as Guaranteed Minimum Death Benefit (“GMDBs”) and Guaranteed Minimum Withdrawal Benefits (“GMWBs”) riders. MRBs are measured at fair value using a risk neutral valuation method, which is based on current net amounts at risk, market data, internal and industry experience, and other factors.
The principal policyholder behavior assumptions used to calculate MRBs are established at issue of the contract and include mortality, contract full and partial surrenders, and utilization of the GMWB rider benefits. The assumptions used reflect a combination of internal experience, industry experience, and judgment. We review overall policyholder behavior experience at least annually and update these assumptions when deemed necessary based on additional information that becomes available. Changes in, or deviations from, the assumptions previously used can significantly affect our MRBs and related results of operations in a positive or negative direction.
Mortality refers to the incidence of death amongst policyholders on covered lives, which triggers contractual death benefit provisions. These provisions may allow for lump sum payments, payments over a period of time, or spousal continuation of the contract. We utilize a combination of actual internal and industry experience when setting our mortality assumptions.
A surrender rate is the percentage of account value surrendered by the policyholder in exchange for receipt of a cash surrender value. We make estimates of expected full and partial surrenders of our deferred annuity products based on a combination of internal and industry experience. Management’s best estimate of surrender generally represents a medium-to-long term perspective, as we expect to experience a range of policyholder behavior and market conditions period to period. If actual surrender rates are significantly different from those estimated, such differences could have a significant effect on our MRBs and related results of operations.
We have been issuing GMWB products since 2008. We make assumptions for policyholder behavior as it relates to GMWB utilization using a higher degree of industry experience and judgment than our other behavioral assumptions because internal experience, which we review annually, is still emerging. If emerging experience deviates from our assumptions on GMWB utilization, it could have a significant effect on MRBs and related results of operations.
Business Overview
We have five distribution channels across retail and institutional markets. Our three retail channels include agent-based Independent Marketing Organizations (“IMOs”), banks and broker dealers. We have deep, long-tenured relationships with our network of leading IMOs and their agents to serve the needs of the middle-income market and develop competitive annuity and life products to align with their evolving needs. Upon FNF’s acquisition of F&G on June 1, 2020 (the “FNF Acquisition), and F&G’s subsequent rating upgrades in mid-2020, we launched into banks and broker dealers. Further, in 2021, we launched into two institutional markets to originate Funding Agreement Backed Notes (“FABN”) and PRT transactions. The FABN Program offers funding agreements to institutional clients by means of capital markets transactions through investment banks. The funding agreements issued under the FABN Program are in addition to those issued to the Federal Home Loan Bank of Atlanta (“FHLB”). The PRT solutions business was launched by building an experienced team and then working with brokers and institutional consultants for distribution. These markets leverage our existing team's spread-based capabilities as well as our strategic partnership with Blackstone.
In setting the features and pricing of our flagship FIA products relative to our targeted net margin, we take into account our expectations regarding (1) the difference between the net investment income we earn and the sum of the interest credited to policyholders and the cost of hedging our risk on the policies; (2) fees, including surrender charges and rider fees, partly offset by vesting bonuses that we pay our policyholders; and (3) a number of related expenses, including benefits and changes in reserves, acquisition costs, and general and administrative expenses.
On March 16, 2022, FNF announced its intention to partially spin off F&G through a dividend to FNF shareholders. On December 1, 2022, FNF distributed, on a pro rata basis, approximately 15% of the common stock of F&G. FNF retained control of F&G through ownership of approximately 85% of F&G common stock. Effective December 1, 2022, F&G commenced “regular-way” trading of its common stock on the New York Stock Exchange (“NYSE”) under the symbol “FG”.
Key Components of Our Historical Results of Operations
Through our insurance subsidiaries, we issue a broad portfolio of deferred annuities (FIA and fixed rate annuities), IUL insurance, immediate annuities, funding agreements and PRT solutions. A deferred annuity is a type of contract that accumulates value on a tax deferred basis and typically begins making specified periodic or lump sum payments a certain number of years after the contract has been issued. IUL insurance is a complementary type of contract that accumulates value in a cash value account and provides a payment to designated beneficiaries upon the policyholder’s death. An immediate annuity is a type of contract that begins making specified payments within one annuity period (e.g., one month or one year) and typically makes payments of principal and interest earnings over a period of time. As defined by the Iowa Insurance Division, a funding agreement is an agreement for an insurer to accept and accumulate funds and to make one or more payments at future dates in amounts that are not based on mortality or morbidity contingencies of the person to whom the funding agreement is issued. In essence, funding agreement providers issue fixed maturity contracts with fixed or floating interest rates in exchange for a single upfront premium. Our PRT products are comparable to income annuities, as we generally receive a single, upfront premium in exchange for paying a guaranteed stream of future income payments which are typically fixed in nature, but may vary in duration based on participant mortality experience.
Under GAAP, premium collections for deferred annuities (FIAs and fixed rate annuities), immediate annuities and PRT without life contingency, and deposits received for funding agreements are reported in the financial statements as deposit liabilities (i.e., contractholder funds) instead of as sales or revenues. Similarly, cash payments to customers are reported as decreases in the liability for contractholder funds and not as expenses. Sources of revenues for products accounted for as deposit liabilities are net investment income, surrender, cost of insurance and other charges deducted from contractholder funds (i.e. amortization of URL), and net realized gains (losses) on investments. Components of expenses for products accounted for as deposit liabilities are interest-sensitive and index product benefits (primarily interest credited to account balances or the hedging cost of providing index credits to the policyholder), amortization of VOBA, DAC, DSI and URL, and other operating costs and expenses.
F&G hedges certain portions of its exposure to product related equity market risk by entering into derivative transactions. We purchase derivatives consisting predominantly of call options and, to a lesser degree, futures contracts (specifically for FIA contracts) on the equity indices underlying the applicable policy. These derivatives are used to offset the reserve impact of the index credits due to policyholders under the FIA and IUL contracts. The majority of all such call options are one-year options purchased to match the funding requirements underlying the FIA/IUL contracts. We attempt to manage the cost of these purchases through the terms of our FIA/IUL contracts, which permit us to change caps, spread, or participation rates on each policy's annual anniversary, subject to certain guaranteed minimums that must be maintained. The call options and futures contracts are marked to fair value with the change in fair value included as a component of net investment gains (losses). The change in fair value of the call options and futures contracts includes the gains and losses recognized at the expiration of the instruments’ terms or upon early termination and the changes in fair value of open positions. In addition, to reduce market risks from interest rate changes on our earnings associated with our floating rate investments, during the nine months ended September 30, 2023 we have executed pay-float and receive-fixed interest rate swaps.
As noted above, MRBs are contracts or contract features that both provide protection to the contract holder from other-than-nominal capital market risk (equity, interest and foreign exchange risk) and expose the Company to other-than-nominal capital market risk. MRBs are measured at fair value using a risk neutral valuation method, which is based on current net amounts at risk, market data, internal and industry experience, and other factors. The change in fair value of MRBs generally reflects impacts from actual policyholder behavior (including surrenders of the benefit), changes in interest rates, and changes in equity market returns. Generally higher interest rates and equity returns result in gains whereas lower interest rates and equity returns result in losses.
Earnings from products accounted for as deposit liabilities are primarily generated from the excess of net investment income earned over the sum of interest credited to policyholders and the cost of hedging our risk on FIA/IUL policies, which includes the expenses incurred to fund the index credits. Proceeds received upon expiration or early termination of call options purchased to fund annual index credits are recorded as part of the change in fair value of derivatives, and are largely offset by an expense for index credits earned on annuity contractholder fund balances.
Our profitability depends in large part upon the amount of AUM (see “—Non-GAAP Financial Measures”), the excess of net investment income earned over the sum of interest credited to policyholders and the cost of hedging our risk on indexed product policies, earned on our average assets under management (“AAUM” — see “—Non-GAAP Financial Measures”), our ability to manage our expenses and the costs of acquiring new business (principally commissions to agents and bonuses credited to policyholders). As we grow AUM, earnings generally increase. AUM increases when cash inflows, which include sales, exceed cash outflows. Managing the excess of net investment income earned over the sum of interest credited to policyholders and the cost of hedging our risk on indexed product policies, involves the ability to maximize returns on our AUM and minimize risks such as interest rate changes and defaults or impairment of investments. It also includes our ability to manage interest rates credited to policyholders and costs of the options and futures purchased to fund the annual index credits on the FIA/IULs. We analyze returns on AAUM to measure our profitability.
Non-GAAP Financial Measures
In addition to reporting financial results in accordance with GAAP, this Quarterly Report on Form 10-Q includes non-GAAP financial measures, which the Company believes are useful to help investors better understand its financial performance, competitive position and prospects for the future. Management believes these non-GAAP financial measures may be useful in certain instances to provide additional meaningful comparisons between current results and results in prior operating periods. Our non-GAAP measures may not be comparable to similarly titled measures of other organizations because other organizations may not calculate such non-GAAP measures in the same manner as we do. The presentation of this financial information is not intended to be considered in isolation of or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. By disclosing these non-GAAP financial measures, the Company believes it offers investors a greater understanding of, and an enhanced level of transparency into, the means by which the Company’s management operates the Company. Any non-GAAP measures should be considered in context with the GAAP financial presentation and should not be considered in isolation or as a substitute for GAAP net earnings, net earnings attributable to common shareholders, or any other measures derived in accordance with GAAP as measures of operating performance or liquidity.
Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP measures are provided within this Quarterly Report on Form 10-Q.
Adjusted Net Earnings
Adjusted net earnings is a non-GAAP economic measure we use to evaluate financial performance each period. Adjusted net earnings is calculated by adjusting net earnings (loss) to eliminate:
(i) Recognized (gains) and losses, net: the impact of net investment gains/losses, including changes in allowance for expected credit losses and other than temporary impairment (“OTTI”) losses, recognized in operations; and the effects of changes in fair value of the reinsurance related embedded derivative and other derivatives, including interest rate swaps and forwards;
(ii) Market related liability adjustments: the impacts related to changes in the fair value, including both realized and unrealized gains and losses, of index product related derivatives and embedded derivatives, net of hedging cost; the impact of initial pension risk transfer deferred profit liability losses, including amortization from previously deferred pension risk transfer deferred profit liability losses; and the changes in the fair value of market risk benefits by deferring current period changes and amortizing that amount over the life of the market risk benefit;
(iii) Purchase price amortization: the impacts related to the amortization of certain intangibles (internally developed software, trademarks and value of distribution asset recognized as a result of acquisition activities);
(iv) Transaction costs: the impacts related to acquisition, integration and merger related items;
(v) Other “non-recurring,” “infrequent” or “unusual items”: Management excludes certain items determined to be “non-recurring,” “infrequent” or “unusual” from adjusted net earnings when incurred if it is determined these expenses are not a reflection of the core business and when the nature of the item is such that it is not reasonably likely to recur within two years and/or there was not a similar item in the preceding two years; and
(vi) Income taxes: the income tax impact related to the above-mentioned adjustments is measured using an effective tax rate, as appropriate by tax jurisdiction.
While these adjustments are an integral part of the overall performance of F&G, market conditions and/or the non-operating nature of these items can overshadow the underlying performance of the core business. Accordingly, management considers this to be a useful measure internally and to investors and analysts in analyzing the trends of our operations. Adjusted net earnings should not be used as a substitute for net earnings (loss). However, we believe the adjustments made to net earnings (loss) in order to derive adjusted net earnings provide an understanding of our overall results of operations.
For example, we could have strong operating results in a given period, yet report net income that is materially less, if during such period the fair value of our derivative assets hedging the FIA and IUL index credit obligations decreased due to general equity market conditions but the embedded derivative liability related to the index credit obligation did not decrease in the same proportion as the derivative assets because of non-equity market factors such as interest rate and non-performance credit spread movements. Similarly, we could also have poor operating results in a given period yet show net earnings (loss) that is materially greater, if during such period the fair value of the derivative assets increased but the embedded derivative liability did not increase in the same proportion as the derivative assets. We hedge our index credits with a combination of static and dynamic strategies, which can result in earnings volatility, the effects of which are generally likely to reverse over time. Our management and board of directors review adjusted net earnings and net earnings (loss) as part of their examination of our overall financial results. However, these examples illustrate the significant impact derivative and embedded derivative movements can have on our net earnings (loss). Accordingly, our management performs a review and analysis of these items, as part of their review of our hedging results each period.
Amounts attributable to the fair value accounting for derivatives hedging the FIA and IUL index credits and the related embedded derivative liability fluctuate from period to period based upon changes in the derivative’s underlying index, changes in the interest rates and non-performance credit spreads used to discount the embedded derivative liability, and the fair value assumptions reflected in the embedded derivative liability. The accounting standards for fair value measurement require the discount rates used in the calculation of the embedded derivative liability to be based on risk-free interest rates adjusted for our non-performance as of the reporting date. The impact of the change in fair values of these derivatives and hedging costs has been removed from net earnings (loss) in calculating adjusted net earnings.
Assets Under Management (“AUM”)
AUM is comprised of the following components and is reported net of reinsurance qualifying for risk transfer in accordance with GAAP:
(i) total invested assets at amortized cost, excluding investments in unconsolidated affiliates and derivatives;
(ii) investments in unconsolidated affiliates at carrying value;
(iii) related party loans and investments;
(iv) accrued investment income;
(v) the net payable/receivable for the purchase/sale of investments; and
(vi) cash and cash equivalents excluding derivative collateral at the end of the period
Management considers this non-GAAP financial measure to be useful internally and to investors and analysts when assessing the size of our investment portfolio that is retained.
Average Assets Under Management (AAUM) (Quarterly and YTD)
AAUM is calculated as AUM at the beginning of the period and the end of each month in the period, divided by the total number of months in the period plus one.
Management considers this non-GAAP financial measure to be useful internally and to investors and analysts when assessing the rate of return on retained assets.
Sales
Annuity, IUL, funding agreement and non-life contingent PRT sales are not derived from any specific GAAP income statement accounts or line items and should not be viewed as a substitute for any financial measure determined in accordance with GAAP. Sales from these products are recorded as deposit liabilities (i.e., contractholder funds) within the Company's consolidated financial statements in accordance with GAAP. Life contingent PRT sales are recorded as premiums in revenues within the consolidated financial statements. Management believes that presentation of sales, as measured for management purposes, enhances the understanding of our business and helps depict longer term trends that may not be apparent in the results of operations due to the timing of sales and revenue recognition.
Yield on AAUM
Yield on AAUM is calculated by dividing annualized net investment income on an adjusted net earnings basis by AAUM. Management considers this non-GAAP financial measure to be useful internally and to investors and analysts when assessing the level of return earned on AAUM.
Results of Operations
The results of operations for the three and nine months ended September 30, 2023 and September 30, 2022 were as follows (in millions):
| Revenues: | Three months ended September 30, 2023 | September 30, 2022 | Nine months ended September 30, 2023 | September 30, 2022 |
|---|---|---|---|---|
| Life insurance premiums and other fees | $582 | $702 | $1,523 | $1,369 |
| Interest and investment income | 578 | 340 | 1,622 | 1,216 |
| Recognized gains and (losses), net | (309) | (140) | (257) | (863) |
| Total revenues | 851 | 902 | 2,888 | 1,722 |
| Benefits and expenses: | ||||
| Benefits and other changes in policy reserves | 292 | 570 | 1,921 | 396 |
| Market risk benefit (gains) losses | (49) | (68) | (20) | (187) |
| Depreciation and amortization | 108 | 82 | 302 | 238 |
| Personnel costs | 58 | 46 | 167 | 110 |
| Other operating expenses | 38 | 28 | 107 | 77 |
| Interest expense | 24 | 6 | 71 | 23 |
| Total benefits and expenses | 471 | 664 | 2,548 | 657 |
| Earnings before income taxes | $380 | $238 | $340 | $1,065 |
| Income tax expense | 74 | 51 | 99 | 254 |
| Net earnings | $306 | $187 | $241 | $811 |
The following table summarizes sales by product type (in millions) (see “Non-GAAP Financial Measures”):
| Three months ended September 30, 2023 | September 30, 2022 | Nine months ended September 30, 2023 | September 30, 2022 | |
|---|---|---|---|---|
| FIA | $1,122 | $1,109 | $3,557 | $3,185 |
| Fixed rate annuities ("MYGA") | 736 | 1,108 | 3,313 | 2,668 |
| Total annuity | 1,858 | 2,217 | 6,870 | 5,853 |
| IUL | 38 | 36 | 117 | 92 |
| Funding agreements | 415 | — | 871 | 1,443 |
| PRT | 470 | 620 | 1,212 | 1,147 |
| Gross Sales | $2,781 | $2,873 | $9,070 | $8,535 |
| Sales attributable to flow reinsurance to third parties | (513) | (660) | (2,381) | (1,440) |
| Net Sales | $2,268 | $2,213 | $6,689 | $7,095 |
- Total annuity sales decreased during the three months ended September 30, 2023, compared to the three months ended September 30, 2022. Coming off higher sales in the first six months of 2023, annuity sales were intentionally lower in the three months ended September 30, 2023 as we expanded our reinsurance agreements and enhanced product features to position our annuity products for the fourth quarter of 2023 and into 2024. Total annuity sales increased for the nine months ended September 30, 2023, compared to the nine months ended September 30, 2022, reflecting execution of the Company’s diversified growth strategy with a disciplined approach to pricing in the current macro environment, given demand for our Retail products due to higher interest rates and market volatility.
- Funding agreements, reflecting new FABN and FHLB agreements during the three and nine months ended September 30, 2023, were higher for the three months ended September 30, 2023 and lower for the nine months ended September 30, 2023 compared to the three and nine months ended September 30, 2022,
respectively, and are subject to fluctuation period to period based on the timing of entering the new agreements.
- PRT sales decreased for the three months ended September 30, 2023 and increased during the nine months ended September 30, 2023, compared to the three and nine months ended September 30, 2022, respectively, reflecting the timing of PRT transactions and are also subject to fluctuation period to period.
- Sales attributable to flow reinsurance to third parties were lower during the three months ended September 30, 2023 and higher during the nine months ended September 30, 2023, compared to the three and nine months ended September 30, 2022, reflecting the level of MYGA sales and include changes in the percentage ceded during the periods.
Revenues
Life insurance premiums and other fees
Life insurance premiums and other fees primarily reflect premiums on life-contingent PRTs and traditional life insurance products, which are recognized as revenue when due from the policyholder, as well as policy rider fees primarily on FIA policies, the cost of insurance on IUL policies and surrender charges assessed against policy withdrawals in excess of the policyholder's allowable penalty-free amounts (up to 10% of the prior year's value, subject to certain limitations). The following table summarizes the Life insurance premiums and other fees, on the unaudited Condensed Consolidated Statements of Operations (in millions), for the three and nine months ended September 30, 2023 and September 30, 2022:
| Three months ended September 30, 2023 | September 30, 2022 | Nine months ended September 30, 2023 | September 30, 2022 | |
|---|---|---|---|---|
| Life-contingent pension risk transfer premiums | $470 | $605 | $1,207 | $1,125 |
| Traditional life insurance premiums | 4 | 4 | 15 | 11 |
| Life-contingent immediate annuity premiums | 8 | 3 | 19 | 15 |
| Surrender charges | 27 | 15 | 66 | 38 |
| Policyholder fees and other income | 73 | 75 | 216 | 180 |
| Life insurance premiums and other fees | $582 | $702 | $1,523 | $1,369 |
- Life insurance premiums and other fees decreased for the three months ended September 30, 2023 and increased for the nine months ended September 30, 2023, compared to the three and nine months ended September 30, 2022 respectively, reflecting the timing of PRT transactions. As noted above, PRT premiums are subject to fluctuation period to period.
- Surrender charges increased for the three and nine months ended September 30, 2023 compared to the three and nine months ended September 30, 2022, primarily reflecting higher amounts assessed against policy withdrawals in excess of the policyholder's allowable penalty-free amounts primarily on our FIA policies.
- Policyholder fees and other income were relatively unchanged for the three months ended September 30, 2023, compared to the three months ended September 30, 2022. Policyholder fees and other income were higher in the nine months ended September 30, 2023, compared to the nine months ended September 30, 2022, primarily due to increased GMWB rider fees, cost of insurance charges on IUL policies and IUL premium loads, net of changes in URL. GMWB rider fees are based on the policyholder's benefit base and are collected at the end of the policy year.
Interest and investment income
Below is a summary of interest and investment income (in millions):
| Three months ended September 30, 2023 | September 30, 2022 | Nine months ended September 30, 2023 | September 30, 2022 | |
|---|---|---|---|---|
| Fixed maturity securities, available-for-sale | $476 | $364 | $1,356 | $1,019 |
| Equity securities | 5 | 4 | 14 | 12 |
| Preferred securities | 9 | 10 | 31 | 36 |
| Mortgage loans | 59 | 48 | 167 | 136 |
| Invested cash and short-term investments | 19 | 10 | 52 | 23 |
| Limited partnerships | 68 | (55) | 169 | 116 |
| Other investments | 5 | 8 | 19 | 15 |
| Gross investment income | $641 | $389 | $1,808 | $1,357 |
| Investment expense | (63) | (49) | (186) | (141) |
| Interest and investment income | $578 | $340 | $1,622 | $1,216 |
Interest and investment income is shown net of amounts attributable to certain funds withheld reinsurance agreements which is passed along to the reinsurer in accordance with the terms of these agreements. Interest and investment income attributable to these agreements, and thus excluded from the totals in the table above, was $102 million and $236 million for the three and nine months ended September 30, 2023, respectively, and $29 million and $67 million for the three and nine months ended September 30, 2022, respectively.
Our AAUM and yield on AAUM are summarized as follows (annualized) (dollars in millions) (see “Non-GAAP Financial Measures”):
| Three months ended September 30, 2023 | September 30, 2022 | Nine months ended September 30, 2023 | September 30, 2022 | |
|---|---|---|---|---|
| AAUM | $46,758 | $41,081 | $45,541 | $39,246 |
| Yield on AAUM (at amortized cost) | 4.93% | 3.31% | 4.73% | 4.12% |
- AAUM was higher for the three and nine months ended September 30, 2023, compared to the three and nine months ended September 30, 2022, reflecting net new business asset flows, stable inforce retention and, for the nine months ended September 30, 2023, net debt proceeds.
- Interest and investment income was higher for the three months ended September 30, 2023 compared to the three months ended September 30, 2022 primarily due to $144 million from returns on alternative investments, $47 million of all other rate impacts and $47 million from invested asset growth.
- Interest and investment income was higher for the nine months ended September 30, 2023 compared to the nine months ended September 30, 2022 primarily due to $199 million from invested asset growth, $122 million from returns on alternative investments and $85 million of all other rate impacts.
Recognized gains and (losses), net
Below is a summary of the major components included in recognized gains and (losses), net (in millions):
| Three months ended September 30, 2023 | September 30, 2022 | Nine months ended September 30, 2023 | September 30, 2022 | |
|---|---|---|---|---|
| Net realized and unrealized (losses) gains on fixed maturity available-for-sale securities, equity securities and other invested assets | $(11) | $(81) | $(88) | $(350) |
| Change in allowance for expected credit losses | (4) | (7) | (33) | (14) |
| Net realized and unrealized (losses) gains on certain derivatives instruments | (327) | (144) | (170) | (846) |
| Change in fair value of reinsurance related embedded derivatives | 36 | 94 | 34 | 357 |
| Change in fair value of other derivatives and embedded derivatives | (3) | (2) | — | (10) |
| Recognized gains and (losses), net | $(309) | $(140) | $(257) | $(863) |
Recognized gains and (losses), net is shown net of amounts attributable to certain funds withheld reinsurance agreements which is passed along to the reinsurer in accordance with the terms of these agreements. Recognized gains and (losses) attributable to these agreements, and thus excluded from the totals in the table above, was $43 million and $42 million for the three and nine months ended September 30, 2023, respectively, and $105 million and $384 million for the three and nine month periods ended September 30, 2022, respectively.
- For the three and nine months ended September 30, 2023, net realized and unrealized gains (losses) on fixed maturity available-for-sale securities, equity securities and other invested assets is primarily the result of realized losses on fixed maturity available-for-sale securities, partially offset by and mark-to-market gains on our equity securities and realized gains on other invested assets.
- For the three and nine months ended September 30, 2022, net realized and unrealized gains (losses) on fixed maturity available-for-sale securities, equity securities and other invested assets is primarily the result of mark-to-market losses on our equity securities and realized losses on fixed maturity available-for-sale securities.
- For all periods, net realized and unrealized gains (losses) on certain derivative instruments primarily relate to the net realized and unrealized gains (losses) on options and futures used to hedge FIA and IUL products, including gains on option and futures expiration and changes in the fair value of interest rate swaps. See the table below for primary drivers of gains (losses) on certain derivatives.
- The fair value of reinsurance related embedded derivative is based on the change in fair value of the underlying assets held in the funds withheld (“FWH”) portfolio.
We utilize a combination of static (call options) and dynamic (long futures contracts) instruments in our product hedging strategy. A substantial portion of the call options and futures contracts are based upon the S&P 500 Index with the remainder based upon other equity, bond and gold market indices.
We utilize interest rate swaps to reduce market risks from interest rate changes on our earnings associated with our floating rate investments.
The components of the realized and unrealized gains (losses) on certain derivative instruments hedging our indexed annuity, universal life products and floating rate investments are summarized in the table below (dollars in millions):
| Call options: | Three months ended September 30, 2023 | September 30, 2022 | Nine months ended September 30, 2023 | September 30, 2022 |
|---|---|---|---|---|
| Realized (losses) gains | $(34) | $(79) | $(193) | $(75) |
| Change in unrealized (losses) gains | (274) | (70) | 38 | (783) |
| Futures contracts: | ||||
| (Losses) gains on futures contracts expiration | — | (4) | 6 | (6) |
| Change in unrealized gains (losses) | (4) | (1) | (5) | (4) |
| Interest rate swaps | (19) | — | (19) | — |
| Foreign currency forward: | ||||
| Gains on foreign currency forward | 4 | 10 | 3 | 22 |
| Total net change in fair value | $(327) | $(144) | $(170) | $(846) |
| Annual Point-to-Point Change in S&P 500 Index during the periods | (4)% | (5)% | 12% | (25)% |
- Realized gains and losses on certain derivative instruments are directly correlated to the performance of the indices upon which the call options and futures contracts are based and the value of the derivatives at the time of expiration compared to the value at the time of purchase. Gains (losses) on option expiration reflect the movement during each period on options settled during the respective period.
- The change in unrealized gains (losses) due to fair value of call options is primarily driven by the underlying performance of the S&P 500 Index during each respective period relative to the S&P 500 Index on the policyholder buy dates.
- The net change in fair value of the call options and futures contracts was primarily driven by movements in the S&P 500 Index relative to the policyholder buy dates.
- The net change in fair value of the interest rate swaps was primarily driven by fluctuations in the interest rate index underlying the swap contracts.
The average index credits to policyholders are as follows:
| Three months ended September 30, 2023 | September 30, 2022 | Nine months ended September 30, 2023 | September 30, 2022 | |
|---|---|---|---|---|
| Average Crediting Rate | 3% | —% | 1% | 1% |
| S&P 500 Index: | ||||
| Point-to-point strategy | 3% | —% | 1% | 1% |
| Monthly average strategy | 2% | —% | 1% | 2% |
| Monthly point-to-point strategy | —% | —% | —% | 1% |
| 3 year high water mark | 5% | 13% | 8% | 12% |
- Actual amounts credited to contractholder fund balances may differ from the index appreciation due to contractual features in the FIA contracts and certain IUL contracts (caps, spreads and participation rates), which allow us to manage the cost of the options purchased to fund the annual index credits.
- The credits for the periods presented were based on comparing the S&P 500 Index on each issue date in the period to the same issue date in the respective prior year periods.
Benefits and expenses
Benefits and other changes in policy reserves
Below is a summary of the major components included in Benefits and other changes in policy reserves (in millions):
| Three months ended September 30, 2023 | September 30, 2022 | Nine months ended September 30, 2023 | September 30, 2022 | |
|---|---|---|---|---|
| PRT agreements | $479 | $609 | $1,233 | $1,141 |
| FIA/IUL market related liability movements | (432) | (209) | 56 | (1,323) |
| Index credits, interest credited & bonuses | 239 | 118 | 543 | 472 |
| Other changes in policy reserves | 6 | 52 | 89 | 106 |
| Total benefits and other changes in policy reserves | $292 | $570 | $1,921 | $396 |
- PRT agreements decreased for the three months ended September 30, 2023 and increased for the nine months ended September 30, 2023, compared to the three and nine months ended September 30, 2022, respectively, reflecting the timing of PRT transactions and are subject to fluctuation period to period.
- The FIA/IUL market related liability movements during the three and nine months ended September 30, 2023 and September 30, 2022, respectively, are mainly driven by changes in the equity markets, non-performance spreads, and risk free rates during the periods. The change in risk free rates and non-performance spreads (decreased) increased the FIA market related liability by $(196) million and $(189) million during the three months ended September 30, 2023 and September 30, 2022, respectively. The change in risk free rates and non-performance spreads (decreased) increased the FIA market related liability by $(190) million and $(748) million during the nine months ended September 30, 2023 and September 30, 2022, respectively. The remaining changes in market value of the market related liability movements for all periods was driven by equity market impacts. See “Revenues — Recognized gains and (losses), net” above for summary and discussion of net unrealized gains (losses) on certain derivative instruments.
- Annually, typically in the third quarter, we review assumptions associated with reserves for policy benefits and product guarantees. During the third quarter of 2023 and for the nine months ended September 30, 2023, based on increases in interest rates and pricing changes, we updated certain FIA assumptions used to calculate the fair value of the embedded derivative component within contractholder funds and also aligned reserves to actual policyholder behavior. These changes resulted in a decrease in total benefits and other changes in policy reserves of approximately $23 million for the three months ended September 30, 2023 and an increase of approximately $74 million for the nine months ended September 30, 2023.
- Index credits, interest credited & bonuses for the three months ended September 30, 2023, were higher compared to the three months ended September 30, 2022, and primarily reflected higher amounts for FIA policies and fixed rate annuities, net of reinsurance, as a result of market movements during the respective periods and higher credits for PRT based on the growth in the portfolio. Index credits, interest credited & bonuses for the nine months ended September 30, 2023, were higher compared to the nine months ended September 30, 2022, and primarily reflected higher amounts for PRT and fixed rate annuities partially offset by lower index credits on FIA policies as a result of market movement during the respective periods. Refer to average policyholder index discussion above for details on drivers.
Market risk benefit (gains) losses
Below is a summary of market risk benefit (gains) losses (in millions):
| Three months ended September 30, 2023 | September 30, 2022 | Nine months ended September 30, 2023 | September 30, 2022 | |
|---|---|---|---|---|
| Market risk benefits (gains) losses | $(49) | $(68) | $(20) | $(187) |
- Market risk benefits (gains) losses is primarily driven by attributed fees collected, effects of market related movements (including changes in equity markets and risk-free rates), actual policyholder behavior as compared with expected and changes in assumptions during the periods. Changes in market risk benefit (gains) losses for the three and nine months ended September 30, 2023, compared to the three and nine months ended September 30, 2022, primarily reflect a favorable GMWB utilization assumption change in 2022, less favorable market related movements and higher attributed fees. In addition, actual policyholder behavior for the three and nine months ended September 30, 2023 was more in line with expected, as compared to the three and nine months ended September 30, 2022, resulting in a favorable change to the market risk benefit (gains) losses.
Depreciation and amortization
Below is a summary of the major components included in depreciation and amortization (in millions):
| Three months ended September 30, 2023 | September 30, 2022 | Nine months ended September 30, 2023 | September 30, 2022 | |
|---|---|---|---|---|
| Amortization of VOBA, DAC and DSI | $101 | $77 | $280 | $216 |
| Amortization of other intangible assets and other depreciation | 7 | 5 | 22 | 22 |
| Total depreciation and amortization | $108 | $82 | $302 | $238 |
- DAC, VOBA and DSI are amortized on a constant level basis for the grouped contracts over the expected term of the related contracts to approximate straight-line amortization. Depreciation and amortization increased for the three and nine months ended September 30, 2023 compared to the three and nine months ended September 30, 2022 and reflected increased DAC and DSI associated with the growth of the business, as well as a slightly increased amortization rate on some DAC and DSI balances due to updates to the surrender and mortality assumptions for the FIA and fixed-rate annuity blocks that occurred in the third quarter of 2023.
Personnel costs and other operating expenses
Below is a summary of personnel costs and other operating expenses (in millions):
| Three months ended September 30, 2023 | September 30, 2022 | Nine months ended September 30, 2023 | September 30, 2022 | |
|---|---|---|---|---|
| Personnel costs | $58 | $46 | $167 | $110 |
| Other operating expenses | 38 | 28 | 107 | 77 |
| Total personnel costs and other operating costs | $96 | $74 | $274 | $187 |
- Personnel costs and other operating expenses for the three and nine months ended September 30, 2023 were higher compared to the three and nine months ended September 30, 2022, and primarily reflect headcount growth to support higher volumes and strategic growth capabilities.
Other items affecting net earnings
Income tax expense (benefit)
Below is a summary of the major components included in income tax expense (benefit) (dollars in millions):
| Three months ended September 30, 2023 | September 30, 2022 | Nine months ended September 30, 2023 | September 30, 2022 | |
|---|---|---|---|---|
| Earnings (loss) before taxes | $380 | $238 | $340 | $1,065 |
| Income tax expense (benefit) before valuation allowance | 79 | 51 | 65 | 216 |
| Change in valuation allowance | (5) | — | 34 | 38 |
| Income tax expense (benefit) | $74 | $51 | $99 | $254 |
| Effective rate | 19% | 21% | 29% | 24% |
- Income tax expense for the three months ended September 30, 2023 was $74 million, compared to income tax expense of $51 million for the three months ended September 30, 2022. The effective tax rate was 19% and 21% for the three months ended September 30, 2023 and September 30, 2022 respectively. The increase in income tax expense quarter over quarter is primarily related to the increase in pre-tax income.
- Income tax expense for the nine months ended September 30, 2023 was $99 million, compared to income tax expense of $254 million for the nine months ended September 30, 2022. The effective tax rate was 29% and 24% for the nine months ended September 30, 2023 and September 30, 2022, respectively. The decrease in income tax expense period over period is primarily related to the decrease in pre-tax income.
Adjusted Net Earnings (See “—Non-GAAP Financial Measures”)
The table below shows the adjustments made to reconcile Net earnings (loss) to Adjusted net earnings (in millions):
| Three months ended September 30, 2023 | September 30, 2022 | Nine months ended September 30, 2023 | September 30, 2022 | |
|---|---|---|---|---|
| Net earnings (loss) | $306 | $187 | $241 | $811 |
| Non-GAAP adjustments: | ||||
| Recognized (gains) and losses, net | ||||
| Net realized and unrealized (gains) losses on fixed maturity available-for-sale securities, equity securities and other invested assets | 14 | 70 | 89 | 336 |
| Change in allowance for expected credit losses | 5 | 6 | 33 | 13 |
| Change in fair value of reinsurance related embedded derivatives | (36) | (94) | (34) | (357) |
| Change in fair value of other derivatives and embedded derivatives | 13 | (7) | 12 | (11) |
| Recognized (gains) losses, net | (4) | (25) | 100 | (19) |
| Market related liability adjustments | (237) | (237) | (95) | (751) |
| Purchase price amortization | 5 | 5 | 16 | 16 |
| Transaction costs and other non-recurring items | 1 | 4 | 3 | 8 |
| Income taxes on non-GAAP adjustments | 49 | 54 | (5) | 158 |
| Adjusted net earnings | $120 | $(12) | $260 | $223 |
The commentary below is intended to provide additional information on the significant income and expense items that help explain the trends in our ANE for each time period, as we believe these items provide further clarity to the financial performance of the business.
- Adjusted net earnings of $120 million for the three months ended September 30, 2023 included $114 million of investment income from alternative investments. Alternative investments investment income based on management’s long-term expected return of approximately 10% was $142 million. Actual investment income was lower due to decreases in fair value of these investments.
- Adjusted net loss of $12 million for the three months ended September 30, 2022 included $11 million of investment loss from alternative investments and $11 million of other net expense items. Alternative investments investment income based on management’s long-term expected return of approximately 10% was $106 million. Actual investment income was lower due to decreases in fair value of these investments.
- Adjusted net earnings of $260 million for the nine months ended September 30, 2023 included $295 million of investment income from alternative investments and $5 million of bond prepay income, offset by $37 million tax valuation allowance. Alternative investments investment income based on management’s long-term expected return of approximately 10% was $411 million. Actual investment income was lower due to decreases in fair value of these investments.
- Adjusted net earnings of $223 million for the nine months ended September 30, 2022 included $161 million of investment income from alternative investments, $66 million gain from actuarial assumption updates, $13 million of other net income and expense items, partially offset by $38 million tax valuation allowance expense. Alternative investments investment income based on management’s long-term expected return of approximately 10% was $306 million. Actual investment income was lower due to decreases in fair value of these investments.
Investment Portfolio
The types of assets in which we may invest are influenced by various state laws, which prescribe qualified investment assets applicable to insurance companies. Within the parameters of these laws, we invest in assets giving consideration to four primary investment objectives: (i) maintain robust absolute returns; (ii) provide reliable yield and investment income; (iii) preserve capital; and (iv) provide liquidity to meet policyholder and other corporate obligations.
Our investment portfolio is designed to contribute stable earnings, excluding short term mark to market effects, and balance risk across diverse asset classes and is primarily invested in high quality fixed income securities.
As of September 30, 2023 and December 31, 2022, the fair value of our investment portfolio was approximately $46 billion and $41 billion, respectively, and was divided among the following asset classes and sectors (dollars in millions):
| Fixed maturity securities, available for sale: | September 30, 2023 Fair Value | Percent | December 31, 2022 Fair Value | Percent |
|---|---|---|---|---|
| United States Government full faith and credit | $99 | —% | $32 | —% |
| United States Government sponsored entities | 34 | —% | 42 | —% |
| United States municipalities, states and territories | 1,485 | 3% | 1,410 | 3% |
| Foreign Governments | 206 | —% | 148 | —% |
| Corporate securities: | ||||
| Finance, insurance and real estate | 6,332 | 14% | 5,085 | 12% |
| Manufacturing, construction and mining | 863 | 2% | 737 | 2% |
| Utilities, energy and related sectors | 2,128 | 5% | 2,275 | 6% |
| Wholesale/retail trade | 2,090 | 5% | 2,008 | 5% |
| Services, media and other | 3,417 | 7% | 2,794 | 7% |
| Hybrid securities | 601 | 1% | 705 | 2% |
| Non-agency residential mortgage-backed securities | 2,135 | 5% | 1,479 | 4% |
| Commercial mortgage-backed securities | 4,109 | 9% | 3,036 | 7% |
| Asset-backed securities | 8,448 | 18% | 7,245 | 18% |
| Collateral loan obligations ("CLO") | 4,924 | 11% | 4,222 | 10% |
| Total fixed maturity available for sale securities | $36,871 | 80% | $31,218 | 76% |
| Equity securities (a) | 721 | 2% | 823 | 2% |
| Limited partnerships: | ||||
| Private equity | 1,153 | 2% | 1,129 | 3% |
| Real assets | 450 | 1% | 431 | 1% |
| Credit | 1,036 | 2% | 867 | 2% |
| Limited Partnerships | 2,639 | 5% | 2,427 | 6% |
| Commercial mortgage loans | 2,148 | 5% | 2,083 | 5% |
| Residential mortgage loans | 2,326 | 5% | 1,892 | 5% |
| Other (primarily derivatives and company owned life insurance) | 1,295 | 3% | 809 | 2% |
| Short term investments | 168 | —% | 1,556 | 4% |
| Total investments | $46,168 | 100% | $40,808 | 100% |
(a) Includes investment grade non-redeemable preferred stocks ($564 million and $672 million at September 30, 2023 and December 31, 2022, respectively).
Insurance statutes regulate the type of investments that our life insurance subsidiaries are permitted to make and limit the amount of funds that may be used for any one type of investment. In light of these statutes and regulations, and our business and investment strategy, we generally seek to invest in primarily high-grade fixed-income assets across a wide range of sectors, including Corporate securities, U.S. Government and government-sponsored agency securities, and Structured securities, among others.
The NAIC’s Securities Valuation Office (“SVO”) is responsible for the day-to-day credit quality assessment and valuation of securities owned by state regulated insurance companies. Insurance companies report ownership of securities to the SVO when such securities are eligible for regulatory filings. The SVO conducts credit analysis on these securities for the purpose of assigning an NAIC designation or unit price. Typically, if a security has been rated by an NRSRO, the SVO utilizes that rating and assigns an NAIC designation based upon the NAIC published comparison of NRSRO ratings to NAIC designations.
The NAIC determines ratings for non-agency Residential Mortgage-backed Securities (“RMBS”) and CMBS using modeling that estimates security level expected losses under a variety of economic scenarios. For such assets issued prior to January 1, 2013, an insurer’s amortized cost basis in applicable assets can impact the assigned rating. In the tables below, we present the rating of structured securities based on ratings from the NAIC rating methodologies described above (which in some cases do not correspond to rating agency designations). All NAIC designations (e.g., NAIC 1-6) are based on the NAIC methodologies.
The following table summarizes the credit quality by NRSRO rating, or NAIC designation equivalent, of our fixed income portfolio (dollars in millions) at September 30, 2023 and December 31, 2022:
| NRSRO Rating | NAIC Designation | September 30, 2023 Fair Value | Fair Value Percent | December 31, 2022 Fair Value | Fair Value Percent |
|---|---|---|---|---|---|
| AAA/AA/A | 1 | $23,567 | 64% | $18,681 | 60% |
| BBB | 2 | 11,373 | 31% | 10,737 | 34% |
| BB | 3 | 1,598 | 4% | 1,425 | 5% |
| B | 4 | 164 | 1% | 236 | 1% |
| CCC | 5 | 66 | —% | 67 | —% |
| CC and lower | 6 | 103 | —% | 72 | —% |
| Total | $36,871 | 100% | $31,218 | 100% |
93
Investment Industry Concentration
The tables below present the top ten industry categories of our fixed maturity and equity securities including the fair value and percent of total fixed maturity and equity securities fair value as of September 30, 2023 and December 31, 2022 (dollars in millions). Effective January 1, 2023, we updated our industry classifications as a result of a change in our investment accounting software and related service providers. Our investment strategy has remained consistent and our portfolio mix has not materially changed. The December 31, 2022 table was updated to reflect a consistent presentation with the September 30, 2023 classifications:
| Top 10 Industry Concentration | September 30, 2023 Fair Value | Percent of Total Fair Value |
|---|---|---|
| ABS Other | $8,448 | 22% |
| CLO securities | 4,924 | 13% |
| Commercial mortgage-backed securities | 4,109 | 11% |
| Diversified financial services | 2,965 | 8% |
| Banking | 2,141 | 6% |
| Whole loan collateralized mortgage obligation | 1,796 | 5% |
| Municipal | 1,485 | 4% |
| Insurance | 1,474 | 4% |
| Electric | 1,001 | 3% |
| Telecommunications | 607 | 2% |
| Total | $28,950 | 78% |
| Top 10 Industry Concentration | December 31, 2022 Fair Value | Percent of Total Fair Value |
|---|---|---|
| ABS Other | $7,245 | 23% |
| CLO securities | 4,222 | 13% |
| Whole loan collateralized mortgage obligation | 3,655 | 12% |
| Banking | 2,855 | 9% |
| Municipal | 1,410 | 4% |
| Electric | 1,379 | 4% |
| Life Insurance | 1,376 | 4% |
| Technology | 855 | 3% |
| Healthcare | 659 | 2% |
| Commercial mortgage-backed securities | 571 | 2% |
| Total | $24,227 | 76% |
94
The amortized cost and fair value of fixed maturity AFS securities by contractual maturities as of September 30, 2023 and December 31, 2022 (dollars in millions), are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations.
| Corporate, Non-structured Hybrids, Municipal and U.S. Government securities: | September 30, 2023 Amortized Cost | Fair Value | December 31, 2022 Amortized Cost | Fair Value |
|---|---|---|---|---|
| Due in one year or less | $270 | $264 | $124 | $123 |
| Due after one year through five years | 3,202 | 3,040 | 2,193 | 2,059 |
| Due after five years through ten years | 2,481 | 2,210 | 1,840 | 1,633 |
| Due after ten years | 15,249 | 11,707 | 14,417 | 11,379 |
| Subtotal | $21,202 | $17,221 | $18,574 | $15,194 |
| Other securities, which provide for periodic payments: | ||||
| Asset-backed securities | 13,880 | 13,372 | 12,209 | 11,467 |
| Commercial-mortgage-backed securities | 4,481 | 4,109 | 3,309 | 3,036 |
| Residential mortgage-backed securities | 2,321 | 2,169 | 1,631 | 1,521 |
| Subtotal | $20,682 | $19,650 | $17,149 | $16,024 |
| Total fixed maturity available-for-sale securities | $41,884 | $36,871 | $35,723 | $31,218 |
Non-Agency RMBS Exposure
Our investment in non-agency RMBS securities is predicated on the conservative and adequate cushion between purchase price and NAIC 1 rating, general lack of sensitivity to interest rates, positive convexity to prepayment rates and correlation between the price of the securities and the unfolding recovery of the housing market.
The fair value of our investments in subprime securities and Alt-A RMBS securities were $34 million and $50 million as of September 30, 2023, respectively, and $40 million and $54 million as of December 31, 2022, respectively. As of September 30, 2023 and December 31, 2022 approximately 96% and 91%, respectively, of the subprime and Alt-A RMBS exposures were rated NAIC 2 or higher.
ABS and CLO Exposures
Our ABS exposures are largely diversified by underlying collateral and issuer type. Our CLO exposures are generally senior tranches of CLOs which have leveraged loans as their underlying collateral.
As of September 30, 2023, the CLO and ABS positions were trading at a net unrealized loss position of $5 million and $485 million, respectively. As of December 31, 2022, the CLO and ABS positions were trading at a net unrealized loss position of $236 million and $499 million, respectively.
The following table summarizes the credit quality by NRSRO rating, or NAIC designation equivalent, of our AFS ABS portfolio (dollars in millions) at September 30, 2023 and December 31, 2022.
| NRSRO Rating | NAIC Designation | September 30, 2023 Fair Value | Percent | December 31, 2022 Fair Value | Percent |
|---|---|---|---|---|---|
| AAA/AA/A | 1 | $6,594 | 78% | $5,570 | 77% |
| BBB | 2 | 1,345 | 16% | 1,232 | 17% |
| BB | 3 | 405 | 5% | 344 | 5% |
| B | 4 | 50 | 1% | 72 | 1% |
| CCC | 5 | 8 | —% | 9 | —% |
| CC and lower | 6 | 46 | —% | 18 | —% |
| Total | $8,448 | 100% | $7,245 | 100% |
The following table summarizes the credit quality by NRSRO rating, or NAIC designation equivalent, of our AFS CLO portfolio (dollars in millions) at September 30, 2023 and December 31, 2022.
| NRSRO Rating | NAIC Designation | September 30, 2023 Fair Value | Percent | December 31, 2022 Fair Value | Percent |
|---|---|---|---|---|---|
| AAA/AA/A | 1 | $2,944 | 60% | $2,678 | 64% |
| BBB | 2 | 1,474 | 30% | 1,225 | 29% |
| BB | 3 | 447 | 9% | 256 | 6% |
| B | 4 | 20 | —% | 19 | —% |
| CCC | 5 | — | —% | 9 | —% |
| CC and lower | 6 | 39 | 1% | 35 | 1% |
| Total | $4,924 | 100% | $4,222 | 100% |
Municipal Bond Exposure
Our municipal bond exposure is a combination of general obligation bonds (fair value of $219 million and $188 million and an amortized cost of $268 million and $231 million as of September 30, 2023 and December 31, 2022, respectively) and special revenue bonds (fair value of $1,264 million and $1,017 million and an amortized cost of $1,546 million and $1,248 million as of September 30, 2023 and December 31, 2022, respectively).
Across all municipal bonds, the largest issuer represented 5% and 6% of the category as of September 30, 2023 and December 31, 2022, respectively, with less than 1% of the entire portfolio and is rated NAIC 1. Our focus within municipal bonds is on NAIC 1 rated instruments, and 98% of our municipal bond exposure is rated NAIC 1 as of September 30, 2023.
Mortgage Loans
Commercial Mortgage Loans
We diversify our commercial mortgage loans ("CMLs") portfolio by geographic region and property type to attempt to reduce concentration risk. We continuously evaluate CMLs based on relevant current information to ensure properties are performing at a level to secure the related debt. LTV and DSC ratios are utilized to assess the risk and quality of CMLs. As of September 30, 2023 and December 31, 2022, our mortgage loans on real estate portfolio each had a weighted average DSC ratio of 2.3 times, and a weighted average LTV ratio of 56% and 57%, respectively.
We consider a CML delinquent when a loan payment is greater than 30 days past due. For mortgage loans that are determined to require foreclosure, the carrying value is reduced to the fair value of the underlying collateral, net of estimated costs to obtain and sell at the point of foreclosure. As of September 30, 2023 and December 31, 2022 we had one CML that was delinquent in principal or interest payments or in process of foreclosure. See Note C - Investments to the Condensed Financial Statements included in this report for additional information on our CMLs, including our distribution by property type, geographic region, LTV and DSC ratios.
Residential Mortgage Loans
Our residential mortgage loans (“RML”) are closed end, amortizing loans, and 100% of the properties are in the United States. We diversify our RML portfolio by state to attempt to reduce concentration risk. RMLs have a primary credit quality indicator of either a performing or nonperforming loan. We define nonperforming RMLs as those that are 90 or more days past due and/or in nonaccrual status.
Loans are placed on nonaccrual status when they are over 90 days delinquent. If a loan becomes over 90 days delinquent, it is our general policy to initiate foreclosure proceedings unless a workout arrangement to bring the loan current can be put in place. See Note C — Investments to the Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q for additional information on our RMLs.
Unrealized Losses
The amortized cost and fair value of the fixed maturity securities and the equity securities that were in an unrealized loss position as of September 30, 2023 and December 31, 2022, were as follows (dollars in millions):
| Fixed maturity securities, available for sale: | September 30, 2023 Number of Securities | Amortized Cost | Allowance for Expected Credit Losses | Unrealized Losses | Fair Value |
|---|---|---|---|---|---|
| United States Government full faith and credit | 17 | $103 | $— | $(4) | $99 |
| United States Government sponsored agencies | 57 | 32 | — | (4) | 28 |
| United States municipalities, states and territories | 212 | 1,794 | — | (331) | 1,463 |
| Foreign Governments | 66 | 257 | — | (57) | 200 |
| Corporate securities: | |||||
| Finance, insurance and real estate | 922 | 7,227 | — | (1,070) | 6,157 |
| Manufacturing, construction and mining | 145 | 1,068 | — | (214) | 854 |
| Utilities, energy and related sectors | 382 | 2,708 | — | (659) | 2,049 |
| Wholesale/retail trade | 448 | 2,636 | — | (578) | 2,058 |
| Services, media and other | 594 | 4,402 | — | (1,010) | 3,392 |
| Hybrid securities | 39 | 654 | — | (72) | 582 |
| Non-agency residential mortgage-backed securities | 369 | 1,943 | (2) | (152) | 1,789 |
| Commercial mortgage-backed securities | 493 | 3,362 | (15) | (367) | 2,980 |
| Asset-backed securities | 922 | 8,888 | (15) | (622) | 8,251 |
| Total fixed maturity available for sale securities | 4,666 | 35,074 | (32) | (5,140) | 29,902 |
| Equity securities | 47 | 665 | — | (128) | 537 |
| Total investments | 4,713 | $35,739 | $(32) | $(5,268) | $30,439 |
97
| Fixed maturity securities, available for sale: | December 31, 2022 Number of Securities | Amortized Cost | Allowance for Expected Credit Losses | Unrealized Losses | Fair Value |
|---|---|---|---|---|---|
| United States Government full faith and credit | 6 | $34 | $— | $(2) | $32 |
| United States Government sponsored agencies | 58 | 39 | — | (4) | 35 |
| United States municipalities, states and territories | 167 | 1,590 | — | (289) | 1,301 |
| Foreign Governments | 44 | 169 | — | (37) | 132 |
| Corporate securities: | |||||
| Finance, insurance and real estate | 526 | 5,586 | (15) | (876) | 4,695 |
| Manufacturing, construction and mining | 120 | 850 | — | (160) | 690 |
| Utilities, energy and related sectors | 333 | 2,825 | — | (644) | 2,181 |
| Wholesale/retail trade | 316 | 2,418 | — | (532) | 1,886 |
| Services, media and other | 360 | 3,354 | — | (783) | 2,571 |
| Hybrid securities | 43 | 706 | — | (84) | 622 |
| Non-agency residential mortgage-backed securities | 241 | 1,353 | (5) | (105) | 1,243 |
| Commercial mortgage-backed securities | 365 | 2,850 | — | (284) | 2,566 |
| Asset-backed securities | 1,147 | 11,511 | (1) | (770) | 10,740 |
| Total fixed maturity available for sale securities | 3,726 | 33,285 | (21) | (4,570) | 28,694 |
| Equity securities | 59 | 879 | — | (174) | 705 |
| Total investments | 3,785 | $34,164 | $(21) | $(4,744) | $29,399 |
The gross unrealized loss position on the fixed maturity available-for-sale fixed and equity portfolio was $5,268 million and $4,744 million as of September 30, 2023 and December 31, 2022, respectively. Most components of the portfolio exhibited price depreciation caused primarily by higher treasury rates. The total amortized cost of all securities in an unrealized loss position was $35,739 million and $34,164 million as of September 30, 2023 and December 31, 2022, respectively. The average market value/book value of the investment category with the largest unrealized loss position was 85% for Finance, insurance and real estate as of September 30, 2023. In the aggregate, Finance, insurance and real estate represented 20% of the total unrealized loss position as of September 30, 2023. The average market value/book value of the investment category with the largest unrealized loss position was 84% for finance, insurance and real estate as of December 31, 2022. In aggregate, finance, insurance and real estate represented 18% of the total unrealized loss position as of December 31, 2022.
The amortized cost and fair value of fixed maturity available for sale securities under watch list analysis and the number of months in a loss position with investment grade securities (NRSRO rating of BBB/Baa or higher) as of September 30, 2023 and December 31, 2022, were as follows (dollars in millions):
| Investment grade: | September 30, 2023 Number of securities | Amortized Cost | Fair Value | Allowance for Credit Loss | Gross Unrealized Losses |
|---|---|---|---|---|---|
| Less than six months | 1 | $4 | $3 | $— | $(1) |
| Six months or more and less than twelve months | 9 | 11 | 7 | — | (4) |
| Twelve months or greater | 158 | 1,858 | 1,198 | — | (660) |
| Total investment grade | 168 | 1,873 | 1,208 | — | (665) |
| Below investment grade: | |||||
| Less than six months | 1 | 5 | 4 | — | (1) |
| Six months or more and less than twelve months | — | — | — | — | — |
| Twelve months or greater | 6 | 25 | 19 | — | (6) |
| Total below investment grade | 7 | 30 | 23 | — | (7) |
| Total | 175 | $1,903 | $1,231 | $— | $(672) |
98
| Investment grade: | December 31, 2022 Number of Securities | Amortized Cost | Fair Value | Allowance for Credit Loss | Gross Unrealized Losses |
|---|---|---|---|---|---|
| Less than six months | 6 | $5 | $3 | $— | $(2) |
| Six months or more and less than twelve months | 49 | 299 | 200 | — | (99) |
| Twelve months or greater | 76 | 969 | 634 | — | (335) |
| Total investment grade | 131 | 1,273 | 837 | — | (436) |
| Below investment grade: | |||||
| Less than six months | 1 | 32 | 13 | 15 | (4) |
| Six months or more and less than twelve months | 12 | 124 | 94 | — | (30) |
| Twelve months or greater | 2 | 6 | 4 | — | (2) |
| Total below investment grade | 15 | 162 | 111 | 15 | (36) |
| Total | 146 | $1,435 | $948 | $15 | $(472) |
Expected Credit Losses and Watch List
We prepare a watch list to identify securities to evaluate for expected credit losses. Factors used in preparing the watch list include fair values relative to amortized cost, ratings and negative ratings actions and other factors. Detailed analysis is performed for each security on the watch list to further assess the presence of credit impairment loss indicators and, where present, calculate an allowance for expected credit loss or direct write-down of a security’s amortized cost.
At September 30, 2023, our watch list included 175 securities in an unrealized loss position with an amortized cost of $1,903 million, no allowance for credit losses, unrealized losses of $672 million and a fair value of $1,231 million.
At December 31, 2022, our watch list included 146 securities in an unrealized loss position with an amortized cost of $1,435 million, allowance for credit losses of $15 million, unrealized losses of $472 million and a fair value of $948 million.
The watch list excludes structured securities as we have separate processes to evaluate the credit quality on the structured securities.
There were 109 and 64 structured securities with a fair value of $734 million and $162 million to which we had potential credit exposure as of September 30, 2023 and December 31, 2022, respectively. Our analysis of these structured securities, which included cash flow testing, resulted in allowances for expected credit losses of $38 million and $16 million as of September 30, 2023 and December 31, 2022, respectively.
Exposure to Sovereign Debt and Certain Other Exposures
Our investment portfolio had an immaterial amount of direct exposure to European sovereign debt as of September 30, 2023 and December 31, 2022, respectively. We have no exposure to investments in Russia or Ukraine and de minimis investments in peripheral countries in the region.
Interest and Investment Income
For discussion regarding our net investment income and net investment gains (losses) refer to Note C -Investments to the Condensed Consolidated Financial Statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q.
AFS Securities
For additional information regarding our AFS securities, including the amortized cost, gross unrealized gains (losses), and fair value as well as the amortized cost and fair value of fixed maturity AFS securities by contractual maturities, as of September 30, 2023 and December 31, 2022, refer to Note C - Investments to the Condensed Consolidated Financial Statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q.
Concentrations of Financial Instruments
For certain information regarding our concentrations of financial instruments, refer to Note C - Investments to the Condensed Consolidated Financial Statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q.
Derivatives
We are exposed to credit loss in the event of nonperformance by our counterparties on derivative instruments. We attempt to reduce this credit risk by purchasing such derivative instruments from large, well-established financial institutions.
We also hold cash and cash equivalents received from counterparties for derivative instrument collateral, as well as U.S. Government securities pledged as derivative instrument collateral, if our counterparty’s net exposures exceed pre-determined thresholds.
We are required to pay counterparties the effective federal funds rate each day for cash collateral posted to F&G for daily mark-to-market margin changes. We reduce the negative interest cost associated with cash collateral posted from counterparties under various ISDA agreements by reinvesting derivative cash collateral. This program permits collateral cash received to be invested in short term Treasury securities, bank deposits and commercial paper rated A1/P1, which are included in Cash and cash equivalents in the accompanying Condensed Consolidated Balance Sheets.
See Note D - Derivatives to the Condensed Consolidated Financial Statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q for additional information regarding our derivatives and our exposure to credit loss on derivatives.
Liquidity and Capital Resources
Liquidity refers to the ability of an enterprise to generate adequate amounts of cash from its normal operations to meet cash requirements with a prudent margin of safety. Our principal sources of cash flow from operating activities are annuity considerations, insurance premiums, and fees and investment income. We also generate cash inflows from investing activities resulting from maturities and sales of invested assets and from financing activities including inflows on our investment-type products and proceeds from borrowing activities. Our operating activities provided cash of $3,612 million and $1,888 million for the nine months ended September 30, 2023 and September 30, 2022, respectively. When considering our liquidity and cash flow, it is important to distinguish between the needs of our insurance subsidiaries and the needs of the holding company, F&G Annuities & Life, Inc. (“FGAL”). As a holding company with no operations of its own, FGAL derives its cash primarily from its insurance subsidiaries and CF Bermuda Holdings Ltd. (“CF Bermuda”), a Bermuda exempted limited liability company and a wholly owned direct subsidiary of the Company, a downstream holding company that provides additional sources of liquidity. Dividends from our insurance subsidiaries flow through CF Bermuda to FGAL. F&G Cayman Re, a licensed class D insurer in the Cayman Islands and a wholly owned direct subsidiary of the Company, could also provide dividends directly to FGAL.
The sources of liquidity of the holding company are principally comprised of dividends from subsidiaries, lines of credit and borrowings (at the FGAL level), existing surplus notes, investment income on holding company assets and the ability to raise long-term public financing under an SEC-filed registration statement or private placement offering. These sources of liquidity and cash flow support the general corporate needs of the holding company, interest and debt service, funding acquisitions and investment in core businesses.
Our cash flows associated with collateral received from and posted with counterparties change as the market value of the underlying derivative contract changes. As the value of a derivative asset declines (or increases), the collateral required to be posted by our counterparties would also decline (or increase). Likewise, when the value of a derivative liability declines (or increases), the collateral we are required to post to our counterparties would also decline (or increase).
Cash Requirements. Our current cash requirements include personnel costs, operating expenses, benefit payments, funding agreement payments, taxes, payments of interest and principal on our debt, capital expenditures, business acquisitions, stock repurchases and dividends on our common stock. We paid dividends of $0.20 per share of common stock in the first, second, and third quarters of 2023, approximately $75 million, to our common shareholders. On November 7, 2023, we announced that our Board of Directors declared a quarterly cash dividend of $0.21 per share, payable on December 29, 2023, to F&G common shareholders of record as of December 15, 2023. There are no restrictions on our retained earnings regarding our ability to pay dividends to our shareholders, although there are limits on the ability of certain subsidiaries to pay dividends to us, as described below. The declaration of any future dividends is at the discretion of our Board of Directors.
On March 21, 2023, F&G’s Board of Directors approved a new three-year stock repurchase program, effective March 21, 2023, under which the Company may repurchase up to $25 million of F&G common stock. The Company believes the share repurchase program is an efficient means of returning cash to shareholders when we consider the shares to be undervalued.
During the nine months ended September 30, 2023, the Company purchased approximately 870 thousand shares pursuant to the program, for a total cost of approximately $18 million with an average cost per share of $21.07.
On November 7, 2023, the Company announced that its Board of Directors has increased the Company’s share repurchase authorization by $25 million to an aggregate of $50 million. This brings the total remaining authorization of F&G common stock that may yet to be purchased under the program from approximately $7 million at September 30, 2023 to approximately $32 million.
Purchases may be made from time to time by the Company in the open market at prevailing market prices or through privately negotiated transactions or accelerated share repurchase transactions through November 6, 2026. All purchases are currently planned to be held as Treasury Stock. The extent to which the Company repurchases its shares, and the timing of such purchases, will depend upon a variety of factors, including market conditions, regulatory requirements and other considerations, as determined by the Company.
On January 13, 2023, F&G completed its issuance and sale of $500 million aggregate principal amount of its 7.40% Senior Notes due 2028 (the "7.40% F&G Notes"). F&G intends to use the net proceeds from the offering for general corporate purposes, including to support the growth of assets under management and for F&G's future liquidity requirements.
On November 22, 2022, we entered into a Credit Agreement (the “Credit Agreement”) with certain lenders (the “Lenders”) and Bank of America, N.A. as administrative agent (in such capacity, the “Administrative Agent”), swing line lender and an issuing bank, pursuant to which the Lenders have made available an unsecured revolving credit facility in an aggregate principal amount of $550 million to be used for working capital and general corporate purposes. As of December 31, 2022, the revolving credit facility was fully drawn with $550 million outstanding. A net partial revolver paydown of $35 million was made on January 6, 2023, and on February 21, 2023, we entered into an amendment with the Lenders to increase the available aggregate principal amount of the Credit Agreement by $115 million to $665 million. As of September 30, 2023, we had $515 million drawn on the revolving credit facility with $150 million of remaining borrowing availability.
As of September 30, 2023 and December 31, 2022, we had cash and cash equivalents of $1,742 million and $960 million, respectively, short term investments of $168 million and $1,556 million, respectively, and available capacity under our revolving credit facility with FNF of $200 million (the “FNF Credit Facility”). No amounts were outstanding under this revolving note agreement as of September 30, 2023 or December 31, 2022. We continually assess our capital allocation strategy, including decisions relating to the amount of our dividend, if any, reducing debt, investing in growth of our subsidiaries, making acquisitions and/or conserving cash. We believe that all anticipated cash requirements for current operations will be met from internally generated funds, through cash dividends from subsidiaries, cash generated by investment securities, potential sales of non-strategic assets, our borrowing availability and potential issuances of additional debt or equity securities. Our short-term and long-term liquidity requirements are monitored regularly to ensure that we can meet our cash requirements. We forecast the needs of all of our subsidiaries and periodically review their short-term and long-term projected sources and uses of funds, as well as the asset, liability, investment and cash flow assumptions underlying such forecasts.
Our two significant sources of internally generated funds are dividends and other payments from our subsidiaries. As a holding company, we receive cash from our subsidiaries in the form of dividends and as reimbursement for operating and other administrative expenses we incur. The reimbursements are paid within the guidelines of management agreements among us and our subsidiaries. As discussed below, our insurance subsidiaries are restricted by state regulation and other laws in their ability to pay dividends and make distributions. As of December 31, 2022, approximately $2.4 billion of our net assets were restricted from dividend payments without prior approval from the relevant departments of insurance.
The maximum dividend permitted by law is not necessarily indicative of an insurer’s actual ability to pay dividends, which may be constrained by business and regulatory considerations, such as the impact of dividends on surplus, which could affect an insurer’s ratings or competitive position, the amount of premiums that can be written and the ability to pay future dividends.
Dividend and Other Distribution Payment Limitations
The insurance laws of Iowa and New York regulate the amount of dividends that may be paid in any year by FGL Insurance and FGL NY Insurance, respectively. Likewise, the insurance laws of Bermuda limit the maximum amount of annual dividends and distributions that may be paid or distributed by F&G Life Re without prior regulatory approval and those of the Cayman Islands require that, among other things, F&G Cayman Re maintain minimum levels of statutory capital, surplus and liquidity, meet solvency standards, submit to periodic examinations of its financial condition and restrict payments of dividends and reductions of capital. Please refer to our Annual Report on Form 10-K for the year ended December 31, 2022 and Note O - F&G Insurance Subsidiary Financial Information and Regulatory Matters included in Item 1 of Part I of this Quarterly Report on Form 10-Q for additional details on dividends from insurance subsidiaries, statutory capital and risk-based capital.
Cash flow from our operations
Cash flow from our operations will be used for general corporate purposes including to reinvest in operations, repay debt, pay dividends, repurchase stock, pursue other strategic initiatives and/or conserve cash.
Operating Cash Flow. Our cash flows provided by operations for the nine months ended September 30, 2023 and September 30, 2022, were $3,612 million and $1,888 million, respectively. The primary cash inflows from operating activities include net investment income and insurance premiums. The primary cash outflows from operating activities are comprised of benefit payments and operating expenses. Cash provided by operations for the nine months ended September 30, 2023 and September 30, 2022 included approximately $655 million and $1,086 million of cash received for PRT transactions, respectively, included in the change in FPBs.
Investing Cash Flows. Our cash used in investing activities for the nine months ended September 30, 2023 and September 30, 2022, were $(5,654) million and, $(6,205) million, respectively. The primary cash inflows from investing activities are the proceeds from sales, calls, maturities and redemptions of investments, including those resulting from the Company's portfolio repositioning. The primary cash outflows from investing activities are the purchases of fixed maturity securities and other investments. Cash used in investing activities for the nine months ended September 30, 2023 and September 30, 2022 included purchases of fixed maturity securities and other investments associated with investing the cash received from investment-type products, generated from financing cash flows, PRT transactions, generated from operating activities, as well as cash received from borrowings generated from financing activities.
Financing Cash Flows. Our cash flows provided by financing activities for the nine months ended September 30, 2023 and September 30, 2022, were $2,824 million and $4,168 million, respectively. The primary cash inflows from financing activities are inflows on our investment-type products and proceeds from borrowing activities. The primary cash outflows from financing activities are withdrawals on our investment-type products, repayments of outstanding borrowings, dividend payments and stock repurchases. Cash provided by financing activities for the nine months ended September 30, 2023 included proceeds of $500 million aggregate principal amount from the issuance and sale of the 7.40% F&G Notes. Cash used by financing activities for the nine months ended September 30, 2023 included the net partial revolver paydown of $35 million, the dividend payments of $75 million and the stock repurchases of $18 million. Cash provided by financing activities for the nine months ended September 30, 2023 and the nine months ended September 30, 2022 included approximately $0 million and $700 million, respectively, of net cash received for FABN transactions.
Financing Arrangements. For a description of our financing arrangements see Note L - Notes Payable to the Condensed Consolidated Financial Statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q for additional information on our financing arrangements.
Equity and Preferred Security Investments. Our equity and preferred security investments may be subject to significant volatility. Currently prevailing accounting standards require us to record the change in fair value of equity and preferred security investments held as of any given period end within earnings. Our results of operations in future periods are anticipated to be subject to such volatility.
Off-Balance Sheet Arrangements. Throughout our history, we have entered into indemnifications in the ordinary course of business with our customers, suppliers, service providers, business partners and in certain instances, when we sold businesses. Additionally, we have indemnified our directors and officers who are, or were, serving at our request in such capacities. Although the specific terms or number of such arrangements is not precisely known due to the extensive history of our past operations, costs incurred to settle claims related to these indemnifications have not been material to our financial statements. We have no reason to believe that future costs to settle claims related to our former operations will have a material impact on our financial position, results of operations or cash flows.
We have unfunded commitments as of September 30, 2023 and December 31, 2022, based upon the timing of when investments and agreements are executed or signed compared to when the actual commitments are funded or closed. Some investments require that funding occur over a period of months or years. Please refer to Note C - Investments and Note N - Commitments and Contingencies to the Condensed Consolidated Financial Statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q for additional details on unfunded commitments.
FHLB Collateral. We are currently a member of the FHLB and are required to maintain a collateral deposit that backs any funding agreements issued. We use these funding agreements as part of a spread enhancement strategy. We have the ability to obtain funding from the FHLB based on a percentage of the value of our assets, subject to the availability of eligible collateral. Collateral is pledged based on the outstanding balances of FHLB funding agreements. The amount of funding varies based on the type, rating and maturity of the collateral posted to the FHLB. Generally, U.S. government agency notes, mortgage-backed securities, municipal bonds, and commercial and residential whole loans are pledged to the FHLB as collateral. Market value fluctuations resulting from changes in interest rates, spreads and other risk factors for each type of asset are monitored and additional collateral is either pledged or released as needed.
Our borrowing capacity under these credit facilities does not have an expiration date as long as we maintain a satisfactory level of creditworthiness based on the FHLB’s credit assessment. As of September 30, 2023 and December 31, 2022, we had $2,354 million and $1,983 million, respectively, in FHLB non-putable funding agreements included under contractholder funds on our Condensed Consolidated Balance Sheet. As of September 30, 2023 and December 31, 2022, we had assets with a fair value of approximately $3,840 million and $3,387 million, respectively, which collateralized the FHLB funding agreements. Assets pledged to the FHLB are primarily included in fixed maturities, AFS, on our Condensed Consolidated Balance Sheets.
Collateral-Derivative Contracts. Under the terms of our ISDA agreements, we may receive from, or deliver to, counterparties collateral to assure that all terms of the ISDA agreements will be met with regard to the Credit Support Annex (“CSA”). The terms of the CSA call for us to pay interest on any cash received equal to the federal funds rate. As of September 30, 2023 and December 31, 2022, $381 million, and $219 million, respectively, of collateral was posted by our counterparties as they did not meet the net exposure thresholds. Collateral requirements are monitored on a daily basis and incorporate changes in market values of both the derivatives contract as well as the collateral pledged. Market value fluctuations are due to changes in interest rates, spreads and other risk factors.
Other. As reported in our Form 8-K dated June 30, 2023, one of the Company’s third-party vendors was a victim of the security incident associated with the MOVEit file transfer system. As a result of this vendor incident, an unauthorized party obtained information in the vendor’s possession for approximately 783,000 of the Company’s policyholders or customers, including social security numbers and account numbers. F&G is a defendant in two putative class action lawsuits related to the alleged compromise of certain of F&G’s customers’ personal information resulting from an alleged vulnerability in the MOVEit file transfer software. Refer to Note N - Commitments and Contingencies to the Condensed Consolidated Financial Statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q for additional information. At this time, F&G does not believe the incident will have a material adverse effect on the Company’s business, operations, or financial results. We remain subject to risks and uncertainties as a result of the incident, including additional litigation and regulatory scrutiny.
Guarantor Financial Information
On January 13, 2023, we issued 7.40% senior notes in the principal amount of $500 million due January 13, 2028 (the “7.40% F&G Notes”). The 7.40% F&G Notes are fully and unconditionally guaranteed on a senior, unsecured, unsubordinated basis, jointly and severally, by each of our existing and future direct and indirect subsidiaries that are guarantors of our obligations under the credit agreement (collectively, the “obligor group”).
Set forth below is summarized unaudited financial information of the obligor group, as presented on a combined basis (dollars in millions). Intercompany transactions and balances within the obligor group have been eliminated. In addition, financial information of any non-guarantor subsidiaries, which would normally be consolidated by either F&G or the guarantors under GAAP, has been excluded from such presentation.
| Summarized Statement of Operations: | Nine months ended September 30, 2023 | Year ended December 31, 2022 |
|---|---|---|
| Total revenue | $(16) | $(21) |
| Total expenses | (68) | (15) |
| Tax (expense) benefit | 12 | 13 |
| Net income (loss) from continuing operations, net of tax | (72) | (22) |
| Summarized Balance Sheet: | September 30, 2023 | December 31, 2022 |
| Investments | $521 | $348 |
| Cash & Cash Equivalents | 167 | 184 |
| Goodwill | 1,725 | 1,725 |
| Due From Non-Guarantor Affiliates | 53 | 40 |
| Other Assets | 32 | 37 |
| Total assets | $2,498 | $2,334 |
| Notes payable | $1,569 | $1,114 |
| Other liabilities | 105 | 127 |
| Total liabilities | $1,674 | $1,241 |
Market risk
As filed, 25,546 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
In the normal course of business, we are routinely subject to a variety of risks, as described in "Part I - Item 1A. Risk Factors" included in our Annual Report on Form 10-K for the year ended December 31, 2022 and Part II - Item 1A. Risk Factors included in this Quarterly Report on Form 10-Q.
The risks related to our business also include certain market risks that may affect our financial instruments and certain liabilities.
At present, we face the market risks associated with our marketable equity securities, liability for Contractholder Funds, and balances for MRBs which are subject to equity price volatility and with interest rate movements on our fixed income investments and liabilities for debt, FPBs, MRBs, and Contractholder Funds.
We regularly assess these market risks and have established policies and business practices designed to protect against the adverse effects of these exposures.
Additionally, financial instruments, which potentially subject us to concentrations of credit risk, consist primarily of cash equivalents, derivatives and short-term investments. We require placement of cash in financial institutions evaluated as highly creditworthy.
Enterprise Risk Management
For information about our enterprise risk management see "Part II - Item 7A. Quantitative and Qualitative Disclosures about Market Risk" included in our Annual Report on Form 10-K for the year ended December 31, 2022.
Asset Liability Management (“ALM”)
As part of our ALM program, we have made a significant effort to identify the assets appropriate to different product lines and ensure investing strategies match the profile of these liabilities. The ALM strategy is designed to align the expected cash flows from the investment portfolio with the expected liability cash flows. As such, a major component of our effort to manage interest rate risk has been to structure the investment portfolio with cash flow characteristics that are consistent with the cash flow characteristics of the insurance liabilities. We use actuarial models to simulate the cash flows expected from the existing business under various interest rate scenarios. These simulations enable us to measure the potential gain or loss in the fair value of interest rate-sensitive financial instruments, to evaluate the adequacy of expected cash flows from assets to meet the expected cash requirements of the liabilities and to determine if it is necessary to lengthen or shorten the average life and duration of our investment portfolio. Duration measures the price sensitivity of a security to a small change in interest rates. When the durations of assets and liabilities are similar, exposure to interest rate risk is minimized because a change in the value of assets could be expected to be largely offset by a change in the value of liabilities.
The duration of the investment portfolio, excluding cash and cash equivalents, derivatives, policy loans, and common stocks as of September 30, 2023 is summarized as follows (dollars in millions):
| Duration (years) | September 30, 2023 Amortized Cost | % of Total |
|---|---|---|
| 0-4 | $22,862 | 50% |
| 5-9 | 10,804 | 24% |
| 10-14 | 10,440 | 23% |
| 15-19 | 1,568 | 3% |
| 20-30 | 76 | —% |
| Total | $45,750 | 100% |
Interest Rate Risk
Interest rate risk is our primary market risk exposure. We define interest rate risk as the risk of an economic loss due to adverse changes in interest rates. This risk arises from investing life insurance premiums and fixed annuity deposits received in interest-sensitive assets and carrying these funds as interest-sensitive liabilities. Substantial and sustained increases or decreases in market interest rates can affect the profitability of the insurance products and the fair value of our investments, as the majority of our insurance liabilities are backed by fixed maturity securities.
Investments
Increases and decreases in prevailing interest rates generally translate into decreases and increases in fair values of investments. Additionally, fair values of interest rate sensitive instruments may be affected by the creditworthiness of the issuer, prepayment options, relative values of alternative investments, the liquidity of the instrument and other general market conditions. We monitor our interest rate risk and make investment decisions to manage the perceived risk. We manage interest rate risk through a variety of measures, including pay-float and receive-fixed interest rate swaps to reduce market risks from interest rate changes on our earnings associated with floating rate investments.
Product Liabilities
The profitability of most of our products depends on the spreads between interest yield on investments and rates credited on insurance liabilities. We have the ability to adjust the rates credited, primarily caps and credit rates, on the majority of the annuity liabilities at least annually, subject to minimum guaranteed values. In addition, the majority of the annuity products have surrender and withdrawal penalty provisions designed to encourage persistency and to help ensure targeted spreads are earned. However, competitive factors, including the impact of the level of surrenders and withdrawals, may limit our ability to adjust or maintain crediting rates at the levels necessary to avoid a narrowing of spreads under certain market conditions.
In order to meet our policy and contractual obligations, we must earn a sufficient return on invested assets. Significant changes in interest rates expose us to the risk of not earning the anticipated spreads between the interest rate earned on its investments and the credited interest rates paid on outstanding policies and contracts. Both rising and declining interest rates can negatively affect interest earnings, spread income and the attractiveness of certain products.
During periods of increasing interest rates, we may offer higher crediting rates on interest-sensitive products, such as IUL insurance and fixed annuities, and may increase crediting rates on in-force products to keep these products competitive. A rise in interest rates, in the absence of other countervailing changes, will result in a decline in the market value of our investment portfolio, partially offset by gains related to the fair value of MRBs.
In addition, at September 30, 2023 we had floating rate funding agreements outstanding. Accordingly, depending on the amounts outstanding during 2023, fluctuations in market interest rates will have an impact on our resulting interest expense. The impact to net earnings, however, will be significantly offset by corresponding changes in investment income associated with our floating rate investments.
Notes Payable
At September 30, 2023, we had a short-term revolving credit facility which bears interest at a floating rate. Accordingly, depending on the amounts outstanding during 2023, fluctuations in market interest rates will have an impact on our resulting interest expense. The impact to net earnings, however, will again be significantly offset by corresponding changes in investment income associated with our floating rate investments.
Equity Price Risk
Equity price risk is the risk that we will incur economic losses due to adverse changes in equity prices. In the past, our exposure to changes in equity prices primarily resulted from our holdings of equity securities. Refer to Note B - Fair Value of Financial Instruments to the Condensed Consolidated Financial Statements included in this Part I - Item 1 of this Quarterly Report on Form 10-Q for additional details on how the carrying values of these investments are determined as of the balance sheet date. Carrying values are subject to fluctuation and, consequently, the amount realized in the subsequent sale of an investment may significantly differ from the reported carrying value. Fluctuation in the carrying value of a security may result from perceived changes in the underlying economic characteristics of the investee, the relative price of alternative investments and general market conditions. Furthermore, amounts realized in the sale of a particular security may be affected by the relative quantity of the security being sold.
We are also exposed to equity price risk through certain insurance products. We offer a variety of FIA/ IUL contracts with crediting strategies linked to the performance of indices such as the S&P 500 Index, Dow Jones Industrials or the NASDAQ 100 Index, and target volatility indices. Additionally, the estimated cost of providing GMWB on FIA products incorporates various assumptions about the overall performance of equity markets over certain time periods. Periods of significant and sustained downturns in equity markets or increased equity volatility could result in an increase in the valuation of the MRB liabilities and decrease in the valuation of contractholder funds liabilities associated with such products.
To economically hedge the equity returns on these products, we purchase derivatives to hedge the FIA and IUL equity exposures. The primary way we hedge FIA/ IUL equity exposure is to purchase over the counter equity index call options from broker-dealer derivative counterparties approved by F&G. The second way to hedge FIA/ IUL equity exposure is by purchasing exchange traded equity index futures contracts. This hedging strategy enables us to reduce the overall hedging costs and achieve a high correlation of returns on the call options purchased relative to the index credits earned by the FIA/ IUL contractholders. The majority of the call options are one-year options purchased to match the funding requirements underlying the FIA/ IUL contracts. These hedge programs are limited to the current policy term of the FIA/ IUL contracts. Future returns, which may be reflected in FIA/ IUL contracts’ credited rates beyond the current policy term, are not hedged. We attempt to manage the costs of these purchases through the terms of the FIA/ IUL contracts, which permit us to change cap, spread or participation rates, subject to certain guaranteed minimums that must be maintained.
The derivatives are used to fund the FIA/ IUL contract index credits and the cost of the call options purchased is treated as a component of spread earnings. While the FIA/ IUL hedging program does not explicitly hedge GAAP income volatility, the FIA/ IUL hedging program tends to mitigate a significant portion of the GAAP reserve changes associated with movements in the equity market. This is due to the fact that a key component in the calculation of GAAP reserves is the market valuation of the current term embedded derivative. Due to the alignment of the embedded derivative reserve component with hedging of this same embedded derivative, there should be a reasonable match between changes in this component of the reserve and changes in the assets backing this component of the reserve. However, there may be an interim mismatch due to the fact that the hedges, which are put in place are only intended to cover exposures expected to remain until the end of an indexing term. To the extent index credits earned by the contractholder exceed the proceeds from option expirations and futures income, we incur a raw hedging loss.
See Note D - Derivative Financial Instruments to the Condensed Consolidated Financial Statements included in Part I - Item 1 of this Quarterly Report on Form 10-Q for additional details on the derivatives portfolio.
Fair value changes associated with these investments are intended to, but do not always, substantially offset the increase or decrease in the amounts added to contractholder funds for indexed products. When index credits to policyholders exceed option proceeds received at expiration related to such credits, any shortfall is funded by our excess of net investment income earned over the sum of interest credited to policyholders and the cost of hedging our risk on indexed product policies and futures income. For the nine months ended September 30, 2023 and September 30, 2022, the annual index credits to policyholders on their anniversaries were $109 million and $148 million, respectively. Proceeds received at expiration of options related to such credits were $109 million and $155 million, respectively.
Other market exposures are hedged periodically depending on market conditions and our risk tolerance. The FIA/ IUL hedging strategy economically hedges the equity returns and exposes us to the risk that unhedged market exposures result in divergence between changes in the fair value of the liabilities and the hedging assets. We use a variety of techniques, including direct estimation of market sensitivities, to monitor this risk daily. We intend to continue to adjust the hedging strategy as market conditions and risk tolerance change.
Sensitivity Analysis
For purposes of this Quarterly Report on Form 10-Q, we perform a sensitivity analysis to determine the effects that market risk exposures may have on various financial instruments.
The financial instruments that are included in the sensitivity analysis with respect to interest rate risk include fixed maturity investments, preferred securities, interest rate swaps and floating rate notes payable and funding agreements. The financial instruments that are included in the sensitivity analysis with respect to equity price risk include marketable equity securities. With the exception of our equity method investments, it is not anticipated that there would be a significant change in the fair value of other long-term investments or short-term investments if there were a change in market conditions, based on the nature and duration of the financial instruments involved.
To perform the sensitivity analysis, we assess the risk of loss in fair values from the effect of hypothetical changes in interest rates and equity prices on market-sensitive instruments. The changes in fair values for interest rate risks are determined by estimating the present value of future cash flows using various models, primarily duration modeling. The changes in fair values for equity price risk are determined by comparing the market price of investments against their reported values as of the balance sheet date.
Information provided by the sensitivity analysis does not necessarily represent the actual changes in fair value that we would incur under normal market conditions because, due to practical limitations, all variables other than the specific market risk factor are held constant.
Market Risk Factors
Market risk is the risk of the loss of fair value resulting from adverse changes in market rates and prices, such as interest rates, foreign currency exchange rates, commodity prices and equity prices. Market risk is directly influenced by the volatility and liquidity in the markets in which the related underlying financial instruments are traded. We have significant holdings in financial instruments, which are naturally exposed to a variety of market risks. They are primarily exposed to interest rate risk, credit risk and equity price risk and have some exposure to counterparty risk, which affect the fair value of financial instruments subject to market risk.
We have no market risk sensitive instruments entered into for trading purposes; therefore, all of our market risk sensitive instruments were entered into for purposes other than trading. The results of the sensitivity analysis at September 30, 2023 is as follows:
Interest Rate Risk
An increase in the levels of interest rates of 100 basis points, with all other variables held constant, would result in a decrease in the fair value of our fixed maturity securities and certain investments in preferred securities of approximately $2.1 billion, a net decrease in the fair value of interest rate swaps of approximately $0.1 billion and a net decrease in the combined fair value of embedded derivatives and MRBs of approximately $0.1 billion at September 30, 2023. In addition, a 100bps shift in interest rates for our floating rate debt and funding agreements will increase or decrease floating interest expense by approximately $12 million per year. As noted above, the impact to net earnings related to the interest rate swaps and floating rate notes payable and funding agreements will be significantly offset by corresponding changes in investment income associated with our floating rate investments.
The actuarial models used to estimate the impact of a one percentage point change in market interest rates incorporate numerous assumptions, require significant estimates and assume an immediate and parallel change in interest rates without any management of the investment portfolio in reaction to such change. Consequently, potential changes in value of financial instruments indicated by these simulations will likely be different from the actual changes experienced under given interest rate scenarios, and the differences may be material. Because we actively manage our investments and liabilities, the net exposure to interest rates can vary over time. However, any such decreases in the fair value of fixed maturity securities, unless related to credit concerns of the issuer requiring allowances for credit losses, would generally be realized only if we were required to sell such securities at losses prior to their maturity to meet liquidity needs. Our liquidity needs are managed using the surrender and withdrawal provisions of the annuity contracts and through other means.
Equity Price Risk
At September 30, 2023, a 10% decrease in market prices, with all other variables held constant, would result in a net decrease in the fair value of our equity securities portfolio of approximately $72 million.
Credit Risk and Counterparty Risk
We are exposed to the risk that a counterparty will default on its contractual obligation resulting in financial loss. Our major source of credit risk arises predominantly in our insurance operations’ portfolios of debt and similar securities. The fair value of our fixed maturity portfolio totaled $37 billion at September 30, 2023. Our credit risk materializes primarily as impairment losses. We are exposed to occasional cyclical economic downturns, during which impairment losses may be significantly higher than the long-term historical average. This is offset by years where it expects the actual impairment losses to be substantially lower than the long-term average. Credit risk in the portfolio can also materialize as increased capital requirements as assets migrate into lower credit qualities over time. The effect of rating migration on our capital requirements is also dependent on the economic cycle and increased asset impairment levels may go hand in hand with increased asset related capital requirements.
We attempt to manage the risk of default and rating migration by applying disciplined credit evaluation and underwriting standards and limiting allocations to lower quality, higher risk investments. In addition, we diversify exposure by issuer and country, using rating-based issuer and country limits. We also set investment constraints that limit our exposure by industry segment. To limit the impact that credit risk can have on earnings and capital adequacy levels, we have portfolio-level credit risk constraints in place. Limit compliance is monitored on a monthly basis.
In connection with the use of derivative instruments, we are exposed to counterparty credit risk-the risk that a counterparty fails to perform under the terms of the derivative contract. We have adopted a policy of only dealing with credit worthy counterparties and obtaining sufficient collateral where appropriate, as a means of attempting to mitigate the financial loss from defaults. The exposure and credit rating of the counterparties are continuously monitored and the aggregate value of transactions concluded is spread amongst different approved counterparties to limit the concentration in one counterparty. This policy allows for the purchase of derivative instruments from counterparties and/or clearinghouses that meet the required qualifications under the insurance laws of Iowa. We review the ratings of all the counterparties periodically. Collateral support documents are negotiated to further reduce the exposure when deemed necessary. See Note D - Derivative Financial Instruments in the Condensed Consolidated Financial Statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q for additional information regarding our exposure to credit loss.
We also have credit risk related to the ability of reinsurance counterparties to honor their obligations to pay the contract amounts under various agreements. To minimize the risk of credit loss on such contracts, we diversify exposures among many reinsurers and limit the amount of exposure to each based on credit rating. We also generally limit selection of counterparties with which to do new transactions to those with an “A-” credit rating or above from at least one of the major rating agencies and/or that are appropriately collateralized and provide credit for reinsurance. When exceptions are made to that principle, we ensure that collateral is obtained to mitigate risk of loss. The following tables present our reinsurance recoverable balances and financial strength ratings for our five largest reinsurance recoverable balances as of September 30, 2023:
(Dollars in millions)
| Parent Company/Principal Reinsurers | September 30, 2023 Financial Strength Rating Reinsurance Recoverable | AM Best | S&P | Fitch | Moody's |
|---|---|---|---|---|---|
| Aspida Life Re Ltd | $5,326 | A- | not rated | not rated | not rated |
| Wilton Re | 1,126 | A+ | not rated | A | not rated |
| Somerset Reinsurance Ltd | 535 | A- | BBB+ | not rated | not rated |
| Canada Life Reinsurance Co. | 104 | A+ | not rated | not rated | not rated |
| Security Life of Denver | 84 | not rated | not rated | A- | Baa1 |
In the normal course of business, certain reinsurance recoverables are subject to reviews by the reinsurers. We are not aware of any material disputes arising from these reviews or other communications with the counterparties as of September 30, 2023 that would require an allowance for uncollectible amounts.
For information on concentrations of reinsurance risk, refer to Note E - Reinsurance in the Condensed Consolidated Financial Statements included in Part I - Item 1 of this Quarterly Report on Form 10-Q.
For further information on certain risk associated with our business, refer to Note N - Commitments and Contingencies in the Condensed Consolidated Financial Statements included in Part I - Item 1 of this Quarterly Report on Form 10-Q.
Use of Estimates and Assumptions
The preparation of our Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions used.
Concentrations of Financial Instruments
Refer to Management's Discussion and Analysis of Financial Condition and Results of Operations - Investment Portfolio - Investment Industry Concentrations included in Item 2 of Part I of this Quarterly Report on Form 10-Q regarding the top ten industry categories of our fixed maturity and equity securities including the fair value and percent of total fixed maturity and equity securities fair value as of September 30, 2023 and December 31, 2022.
Refer to Note C - Investments in the Condensed Consolidated Financial Statements included in Part I - Item 1 of this Quarterly Report on Form 10-Q for our underlying investment concentrations that exceed 10% of shareholders equity as of September 30, 2023.
Concentrations of Financial and Capital Markets Risk
We are exposed to financial and capital markets risk, including changes in interest rates and credit spreads, which can have an adverse effect on our results of operations, financial condition and liquidity. Exposure to such financial and capital markets risk relates primarily to the market price and cash flow variability associated with changes in interest rates. A rise in interest rates, in the absence of other countervailing changes, will increase the net unrealized loss position and, if long-term interest rates rise dramatically within a six- to twelve-month time period, certain of our products may be exposed to disintermediation risk. Disintermediation risk refers to the risk that policyholders surrender their contracts in a rising interest rate environment, requiring us to liquidate assets in an unrealized loss position. We attempt to mitigate the risk, including changes in interest rates by investing in less rate-sensitive investments, including senior tranches of collateralized loan obligations, non-agency residential mortgage-backed securities, and various types of asset-backed securities. Management believes this risk is also mitigated to some extent by surrender charge protection provided by our products. We expect to continue to face these challenges and uncertainties that could adversely affect our results of operations and financial condition.
Controls and procedures
As filed, 2,591 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
As of the end of the period covered by this report, we carried out an evaluation was performed under the supervision and with participation of the Company’s management, including the Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")), as of the end of the period covered by this report. Based on that evaluation, the Company’s management, including the CEO and CFO, concluded that, as of September 30, 2023, the Company’s disclosure controls and procedures were effective to ensure that information we are required to disclose in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, and is accumulated and communicated to the Company’s management, including the Company’s CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.
Notwithstanding the foregoing, there can be no assurance that the Company’s disclosure controls and procedures will detect or uncover all failures of persons within the Company to disclose material information otherwise required to be set forth in the Company’s periodic reports. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable, not absolute, assurance of achieving their control objectives.
Changes in Internal Control Over Financial Reporting
There were no changes in the Company’s internal control over financial reporting that occurred during the quarter ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
Limitations on the Effectiveness of Controls
A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.
Risk factors
As filed, 7,826 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
In addition to the information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the "Risk Factors" disclosed under "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022. You should be aware that these risk factors and other information may not describe every risk facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.
We adopted Accounting Standards Update (“ASU”) 2018-12, Financial Services-Insurance (Topic 944), Targeted Improvements to the Accounting for Long-Duration Contracts (“ASU 2018-12”) on January 1, 2023, with a transition date of January 1, 2021, or the beginning of the earliest period that will be presented in the annual December 31, 2023 Consolidated Financial Statements. We elected to adopt ASU 2018-12 using the full retrospective transition method and balances for liability for future policy benefits (“FPB”), deferred acquisition costs ("DAC”) and balances amortized on a basis consistent with DAC (value of business acquired ("VOBA”), deferred sales inducements (“DSI”), and unearned revenue liabilities (“URL”), and market risk benefits (“MRBs”) were adjusted to conform to ASU 2018-12 starting as of the FNF Acquisition Date, June 1, 2020 (the “FNF Acquisition Date”). The following updates to Risk Factors relate to the adoption of ASU 2018-12. There have been no other material changes from the Risk Factors previously disclosed in "Item 1A. Risk Factors" in our Annual Report filed with the SEC on February 27, 2023 and hereby incorporated by reference.
ASU 2018-12 requires that VOBA, DAC and DSI be amortized on a constant level basis for the grouped contracts over the expected term of the related contracts to approximate straight-line amortization. Based on this change, we have removed the risk factor previously titled “The pattern of amortizing our VOBA, DAC and DSI balances relies on assumptions and estimates made by management. Changes in these assumptions and estimates could impact our results of operations and financial condition.”
Interest rate fluctuations could adversely affect our business, financial condition, liquidity and results of operations.
Interest rate risk is a significant market risk for us, as our business involves issuing interest rate sensitive obligations backed primarily by investments in fixed income assets. As of December 31, 2022, we also maintained approximately 18% of the assets in our investment portfolio in floating rate instruments and had executed a variable interest rate Credit Agreement, which are both subject to an element of market risk from changes in interest rates.
Prior to 2022, interest rates had been at or near historical low levels over the preceding several years. A prolonged period of low rates exposes us to the risk of not achieving returns sufficient to meet our earnings targets and/or our contractual obligations. Furthermore, low or declining interest rates may reduce the rate of policyholder surrenders and withdrawals on our life insurance and annuity products, thus increasing the duration of the liabilities, creating asset and liability duration mismatches and increasing the risk of having to reinvest assets at yields below the amounts required to support our obligations. Lower interest rates may also result in decreased sales of certain insurance products, negatively impacting our profitability from new business.
During periods of increasing interest rates, we may offer higher crediting rates on interest-sensitive products, such as universal life insurance and fixed rate annuities, and we may increase crediting rates on in-force products to keep these products competitive. We may be required to accept lower spread income (the difference between the returns we earn on our investments and the amounts we credit to contract holders), thus reducing our profitability, as returns on our portfolio of invested assets may not increase as quickly as current interest rates. Rapidly rising interest rates may also expose us to the risk of financial disintermediation, which is an increase in policy surrenders, withdrawals and requests for policy loans as customers seek to achieve higher returns elsewhere, requiring us to liquidate assets in an unrealized loss position. If we experience unexpected withdrawal activity, we could exhaust our liquid assets and be forced to liquidate other less liquid assets such as limited partnership investments. We may have difficulty selling these investments in a timely manner and/or be forced to sell them for less than we otherwise would have been able to realize, which could have a material adverse effect on our business, financial condition or operating results. We have developed and maintain asset liability management (“ALM”) programs and procedures that are, we believe, designed to mitigate interest rate risk by matching asset cash flows to expected liability cash flows. In addition, we assess surrender charges on withdrawals in excess of allowable penalty-free amounts that occur during the surrender charge period. There can be no assurance that actual withdrawals, contract benefits, and maturities will match our estimates. Despite our efforts to reduce the impact of rising interest rates, we may be required to sell assets to raise the cash necessary to respond to an increase in surrenders, withdrawals and loans, thereby realizing capital losses on the assets sold.
Liabilities that are held on our balance sheet at fair value, including embedded derivatives on our FIA and IUL business and MRBs on our FIA and fixed rate annuity business, are sensitive to fluctuations in interest rates. Decreases in interest rates generally would have the impact of increasing the value of these liabilities, which will result in a reduction in our net income. Liabilities for FPBs are valued using locked-in discount rates, and any changes in interest rates since the inception of those contracts are reflected in OCI. Decreases in interest rates would result in a reduction in our OCI. In addition, certain statutory capital and reserve requirements are based on formulas or models that consider interest rates and a prolonged period of low interest rates may increase the statutory capital we are required to hold as well as the amount of assets we must maintain to support statutory reserves.
As of September 30, 2023, current economic conditions, including higher interest rates, have not adversely affected our business, results of operations and financial condition. However, we cannot predict if it will impact our business, results of operations and financial condition in the future for the forgoing reasons. Higher interest rates have decreased the fair value of our investment security portfolio as of September 30, 2023 and December 31, 2022, primarily our fixed maturity securities, resulting in our AOCI being a loss of $3.0 billion and $2.8 billion, respectively. See “Quantitative and Qualitative Disclosure about Market Risk” in this Quarterly Report on Form 10-Q for a more detailed discussion of interest rate risk.
Equity market volatility could negatively impact our business.
The estimated cost of providing guaranteed minimum withdrawal benefit riders associated with our annuity products incorporates various assumptions about the overall performance of equity markets over certain time periods. Periods of significant and sustained downturns in equity markets or increased equity volatility could result in an increase in the valuation of the MRBs or contractholder funds liabilities associated with such products, resulting in a reduction in our revenues and net income.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-07-01 to 2023-09-30 | $851.0m | us-gaap:Revenues |
| Revenue | 9 months2023-01-01 to 2023-09-30 | $2.89bn | us-gaap:Revenues |
| Interest expense | 3 months2023-07-01 to 2023-09-30 | $24.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2023-01-01 to 2023-09-30 | $71.0m | us-gaap:InterestExpense |
| Income tax | 3 months2023-07-01 to 2023-09-30 | $74.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-01-01 to 2023-09-30 | $99.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-07-01 to 2023-09-30 | $306.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-01-01 to 2023-09-30 | $241.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-07-01 to 2023-09-30 | $2.45 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-01-01 to 2023-09-30 | $1.93 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-07-01 to 2023-09-30 | $2.47 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-01-01 to 2023-09-30 | $1.94 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-07-01 to 2023-09-30 | 125,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-01-01 to 2023-09-30 | 125,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-01-01 to 2023-09-30 | $3.61bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 9 months2023-01-01 to 2023-09-30 | $75.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2023-01-01 to 2023-09-30 | $18.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-09-30 | $1.74bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2023-09-30 | $63.62bn | us-gaap:Assets |
| Total liabilities | At period end2023-09-30 | $61.25bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-09-30 | $1.57bn | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2023-09-30 | $2.37bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001934850-23-000068. Last ingested by Listed: Nov 13, 2026, 16:26 ET. Listed shows no prices and gives no investment advice.